US20040045566A1 - Tobacco smoke filter and relative composition made of antioxidant and mineral substances - Google Patents
Tobacco smoke filter and relative composition made of antioxidant and mineral substances Download PDFInfo
- Publication number
- US20040045566A1 US20040045566A1 US10/657,473 US65747303A US2004045566A1 US 20040045566 A1 US20040045566 A1 US 20040045566A1 US 65747303 A US65747303 A US 65747303A US 2004045566 A1 US2004045566 A1 US 2004045566A1
- Authority
- US
- United States
- Prior art keywords
- tobacco smoke
- approximately
- mgs
- smoke filter
- filter composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000779 smoke Substances 0.000 title claims abstract description 167
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 139
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 239000000126 substance Substances 0.000 title claims abstract description 53
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 49
- 239000011707 mineral Substances 0.000 title claims abstract description 49
- 244000061176 Nicotiana tabacum Species 0.000 title description 110
- 230000003078 antioxidant effect Effects 0.000 title description 11
- 229910000859 α-Fe Inorganic materials 0.000 claims abstract description 38
- 239000002516 radical scavenger Substances 0.000 claims abstract description 10
- 229940123457 Free radical scavenger Drugs 0.000 claims abstract description 6
- 241000208125 Nicotiana Species 0.000 claims abstract 29
- 150000003254 radicals Chemical class 0.000 claims description 73
- 235000019504 cigarettes Nutrition 0.000 claims description 67
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 65
- 235000006708 antioxidants Nutrition 0.000 claims description 62
- 230000000391 smoking effect Effects 0.000 claims description 59
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 36
- 235000011649 selenium Nutrition 0.000 claims description 36
- 229910052711 selenium Inorganic materials 0.000 claims description 36
- 239000011669 selenium Substances 0.000 claims description 36
- 229940091258 selenium supplement Drugs 0.000 claims description 35
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 31
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 29
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 29
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims description 27
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims description 27
- 229960003987 melatonin Drugs 0.000 claims description 27
- 239000002245 particle Substances 0.000 claims description 27
- 239000007789 gas Substances 0.000 claims description 26
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 18
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 13
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 13
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 13
- 235000021283 resveratrol Nutrition 0.000 claims description 13
- 229940016667 resveratrol Drugs 0.000 claims description 13
- 239000003183 carcinogenic agent Substances 0.000 claims description 12
- 235000019506 cigar Nutrition 0.000 claims description 12
- JYIBXUUINYLWLR-UHFFFAOYSA-N aluminum;calcium;potassium;silicon;sodium;trihydrate Chemical compound O.O.O.[Na].[Al].[Si].[K].[Ca] JYIBXUUINYLWLR-UHFFFAOYSA-N 0.000 claims description 11
- 229910001603 clinoptilolite Inorganic materials 0.000 claims description 11
- 102000006587 Glutathione peroxidase Human genes 0.000 claims description 10
- 108700016172 Glutathione peroxidases Proteins 0.000 claims description 10
- 229940067596 butylparaben Drugs 0.000 claims description 9
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 9
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 8
- 229910021536 Zeolite Inorganic materials 0.000 claims description 8
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 8
- 229940045803 cuprous chloride Drugs 0.000 claims description 8
- 239000010457 zeolite Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- RWSXRVCMGQZWBV-PHDIDXHHSA-N L-Glutathione Natural products OC(=O)[C@H](N)CCC(=O)N[C@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-PHDIDXHHSA-N 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 6
- 150000003669 ubiquinones Chemical class 0.000 claims description 5
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 229960004106 citric acid Drugs 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003610 charcoal Substances 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 108010063907 Glutathione Reductase Proteins 0.000 claims description 2
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 claims description 2
- ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 claims description 2
- 229930182853 L-selenocysteine Natural products 0.000 claims description 2
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims description 2
- 229960002718 selenomethionine Drugs 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 description 36
- 210000004027 cell Anatomy 0.000 description 33
- 206010028980 Neoplasm Diseases 0.000 description 31
- 201000011510 cancer Diseases 0.000 description 25
- 230000006378 damage Effects 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 19
- 239000011269 tar Substances 0.000 description 19
- -1 Superoxide radicals Chemical class 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 230000001473 noxious effect Effects 0.000 description 17
- 239000000356 contaminant Substances 0.000 description 16
- 238000001914 filtration Methods 0.000 description 16
- 230000000711 cancerogenic effect Effects 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 231100000315 carcinogenic Toxicity 0.000 description 14
- 208000020816 lung neoplasm Diseases 0.000 description 14
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 13
- 229920002301 cellulose acetate Polymers 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 108010024636 Glutathione Proteins 0.000 description 12
- 229960003180 glutathione Drugs 0.000 description 12
- 201000005202 lung cancer Diseases 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 239000003570 air Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 9
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 9
- 229910002091 carbon monoxide Inorganic materials 0.000 description 9
- 230000034994 death Effects 0.000 description 9
- 231100000517 death Toxicity 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 229960002715 nicotine Drugs 0.000 description 9
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 239000002250 absorbent Substances 0.000 description 8
- 230000002745 absorbent Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000005192 partition Methods 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 231100000357 carcinogen Toxicity 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000002485 combustion reaction Methods 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 7
- 210000000987 immune system Anatomy 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 230000009977 dual effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000003859 lipid peroxidation Effects 0.000 description 6
- 238000007348 radical reaction Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 206010014561 Emphysema Diseases 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 210000004081 cilia Anatomy 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000002085 irritant Substances 0.000 description 5
- 231100000021 irritant Toxicity 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 231100000670 co-carcinogen Toxicity 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 229910052596 spinel Inorganic materials 0.000 description 4
- 239000011029 spinel Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010047623 Vitamin C deficiency Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000009533 lab test Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000005291 magnetic effect Effects 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 208000010233 scurvy Diseases 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 229910052712 strontium Inorganic materials 0.000 description 3
- 239000002341 toxic gas Substances 0.000 description 3
- 230000004614 tumor growth Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- TXVHTIQJNYSSKO-UHFFFAOYSA-N BeP Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC4=CC=C1C2=C34 TXVHTIQJNYSSKO-UHFFFAOYSA-N 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000383 hazardous chemical Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 206010023841 laryngeal neoplasm Diseases 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-methyl-PhOH Natural products CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 150000004005 nitrosamines Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N para-hydroxytoluene Natural products CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
- RSGFPIWWSCWCFJ-VAXZQHAWSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O RSGFPIWWSCWCFJ-VAXZQHAWSA-N 0.000 description 1
- MNIQECRMTVGZBM-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;7h-purin-6-amine Chemical compound NC1=NC=NC2=C1NC=N2.CN1CCCC1C1=CC=CN=C1 MNIQECRMTVGZBM-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010001914 Amblyopia tobacco Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000019542 Cured Meats Nutrition 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 231100001074 DNA strand break Toxicity 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022004 Influenza like illness Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 229910017916 MgMn Inorganic materials 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000021063 Respiratory fume inhalation disease Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 241000791876 Selene Species 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910003481 amorphous carbon Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000004054 benzoquinones Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 239000002802 bituminous coal Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 208000025188 carcinoma of pharynx Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 210000000254 ciliated cell Anatomy 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000567 combustion gas Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- MLUCVPSAIODCQM-NSCUHMNNSA-N crotonaldehyde Chemical compound C\C=C\C=O MLUCVPSAIODCQM-NSCUHMNNSA-N 0.000 description 1
- MLUCVPSAIODCQM-UHFFFAOYSA-N crotonaldehyde Natural products CC=CC=O MLUCVPSAIODCQM-UHFFFAOYSA-N 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000007911 effervescent powder Substances 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000005307 ferromagnetism Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000002737 fuel gas Substances 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 239000008246 gaseous mixture Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000004536 heart mitochondria Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 150000004680 hydrogen peroxides Chemical class 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003077 lignite Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- VASIZKWUTCETSD-UHFFFAOYSA-N manganese(II) oxide Inorganic materials [Mn]=O VASIZKWUTCETSD-UHFFFAOYSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000002006 petroleum coke Substances 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NOTVAPJNGZMVSD-UHFFFAOYSA-N potassium monoxide Inorganic materials [K]O[K] NOTVAPJNGZMVSD-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000009613 pulmonary function test Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000026313 regulation of carbohydrate metabolic process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- SPVXKVOXSXTJOY-UHFFFAOYSA-N selane Chemical compound [SeH2] SPVXKVOXSXTJOY-UHFFFAOYSA-N 0.000 description 1
- 229910000058 selane Inorganic materials 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 208000029517 toxic amblyopia Diseases 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 125000001655 ubiquinone group Chemical group 0.000 description 1
- UIXPTCZPFCVOQF-UHFFFAOYSA-N ubiquinone-0 Chemical class COC1=C(OC)C(=O)C(C)=CC1=O UIXPTCZPFCVOQF-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 239000011364 vaporized material Substances 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/04—Tobacco smoke filters characterised by their shape or structure
- A24D3/048—Tobacco smoke filters characterised by their shape or structure containing additives
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/16—Use of materials for tobacco smoke filters of inorganic materials
Definitions
- the present invention relates to the technical sector of smoking articles and in particular of tobacco smoke filter and relative compositions to insert in cigarettes, cigars and pipes.
- Cigarette smoking is one of the greatest public health problems in the world. Its adverse effect range from mild physical complaints (bad breath, stained fingers and teeth) to a documented decrease in life span. Smoking is known to be a contributing and perhaps the major factor in various forms of health and blood vessel disease, lung cancer, stroke, emphysema and chronic bronchitis.
- Lung cancer is one of the most difficult cancers to be treated. It is difficult to detect in its early stage, so that it often has a death grip treatment is begun. Only 13 percent of lung-cancer patients live five years or more after diagnosis. Some 85 percent of lung cancer in men is due to smoking; 75 percent of lung cancer in women is due to smoking.
- Smoking increases the risk not only of lung cancer but also of cancers of the lip, mouth, throat, larynx, esophagus, bladder, pancreas and kidney. It may be associated with cancer of the stomach and cervix, although not indirect contact with tobacco smoke are affected by the substance that the body adsorbs or metabolizes from tobacco components. The pollutants flow through the blood stream to pancreas, bladder and kidney. Unfortunately most smokers do not usually stop smoking until the onset of ill health.
- Free radicals are mentioned often in their role causing cancer, heart disease and aging. Let have a detailed look at free radicals to better understand how they cause such extensive and seemingly unrelated damage.
- a free radical is an incomplete molecule. It is a fragment of a molecule that is highly reactive, because its electron arrangement is out of balance. Atoms, molecules and ions are more stable entities because they have more balanced electron arrangements.
- the highly reactive free radicals do more damage than that of one molecule to one molecule reaction.
- Each free radical is capable of destroying an enzyme or protein molecule or destroying an entire cell.
- the damage is much more extensive than that because each free radical usually generates a chain of free radical reactions resulting in thousands of free radicals being released to destroy body components.
- This biological magnification occurs for two reasons. The first and most important is the enormous sensitivity of the cell to modification in its heredity apparatus such as its DNA.
- the chromosomes which control the reproduction of the cell, are extremely radiation sensitive; the cytoplasm is much less so. Largely, because of the sensitivity of DNA, radiations that destroy only one molecule in one million or ten million in the cell can be lethal.
- the second cause of biological magnification is that any polymeric system is sensitive to small chemical changes and many important biomolecules are polymers.
- Free radical reactions leading to cell membrane damage can cause cancer, heart disease or accelerated aging. There are five basic types of damage caused by free radicals that accelerate aging.
- glutathione peroxidase protects cells from mutagenic peroxides formed from DNA and nucleotides. It also breaks down lipid (fat) peroxides that can contribute to arteriosclerosis. It is also involved in the regulation of carbohydrate metabolism and in the maintenance of the integrity of red blood cells. It protects the membranes of liver-cell mitochondria (the cell's energy factors) from damage by peroxides. Glutathione peroxidase is also involved in the prostaglandin metabolism and in the killing of bacteria by white cells.
- Irritants cause immediate coughing and broncho-constriction after smoke inhalation, inhibit cilial action in the bronchial epithelium, stimulate mucous secretion suppress protease inhibition and impair alveolar macrophage function.
- Toxic gases in cigarette smoke include CO, hydrogen sulfide, hydrocyanic acid, and oxides of nitrogen.
- the average carboxy-hemoglobin level in people smoking one pack/day is about 5% compared to ⁇ 1% in nonsmokers. This reduced the amount of Hb available of transport and shifts to the left the Hb-dissociation curve, impairing realize to the tissues.
- a free radical is in an atom or group of atoms that contains at least one unpaired electron. Electrons are negatively charged particles that usually occur in pairs, forming a chemically stable arrangement. If an electron is unpaired, another atom or molecule can easily bond with it, causing a chemical reaction. Because they join so readily with other compounds, free radicals can effect dramatic changes in the body, and they can cause a lot of damage. Each free radical may exist for a tiny fraction of a second, but the damage it leaves behind can be irreversible.
- Cigarette smoking accelerates arteriosclerosis and may double the risk of myocardial infarction. Smoking may precipitate in anginal attack or ischemic ECG changes in patients with coronary artery disease. The risk of developing disease, peripheral vascular disease, or nonsyphylitic aortic aneurysm is also increased in smokers.
- Pregnancy The mean birth weight of infants born to mothers who smoke during pregnancy is 6 oz. Less than of infants to nonsmoking mothers. The incidence of spontaneous abortion, stillbirth and neonatal death may also be increased in pregnant women who smoke.
- Extra-pulmonary cancers associated with cigarette smoking include cancer of the mouth, pharynx, larynx, esophagus, bladder and pancreas.
- Peptic (especially gastric) ulceration occurs more frequently and has a higher mortality rate in cigarette smokers than in non-smokers.
- the effectiveness of medical treatment for peptic ulceration is reduced and the rate of ulcer healing is slowed.
- Pulmonary TB is more in smokers, perhaps due to activation of old tuberculosis foci.
- Tobacco amblyopia may be caused by optic nerve damage due to the toxic action of cyanides in cigarette smoke in smokers with vitamins deficiency.
- the body's respiratory system for example has a well-defined local defense system.
- the cilia prevent accumulation, if inhaled matter in the lungs by transporting the particles away from the lungs. If deciliated cells are rendered ineffective by smoke or other irritants, cells called macrophages take up their work by engulfing and digesting hazardous substances such as bacteria.
- Free radicals, chemicals and gases irritate the mucous membranes and damage the cilia that catch foreign matter in the passages. After years of being exposed to smoke the cilia are destroyed and the entire lung is partially or completely blackened depending on how much and how long one has smoked.
- the cells lining the air passages may begin to transform because of continuous exposure to free radicals and chemical carcinogens. These cells than become irregular, clump together and over a period of years may form a growing tumor.
- cancer breaks away from the lung and travels through the lymphomatic system to the organs. Metastasic tumor develops and the cancer is then usually beyond treatment.
- the combustion of tobacco leaves at about 1000 C. Leads to the formation of a high concentration of free radicals and a large variety of inorganic or organic gases, liquids, and solids.
- Cigarette smoke contains well over four thousand chemicals along with a number of unknown products and additives that are not regulated by agencies outside the tobacco industry (nor obviously by anyone within it). They may include pesticides (used to protect the tobacco plants from bugs), some of which have not been tested for safety.
- Cigarette smoking contains 2 percent to 6 percent carbon monoxide.
- everyone living in the industrialized world loose some hemoglobin to carbon monoxide found in the air.
- smokers lose up 15 percent. This means that smokers run a much higher risk that vital organs will not receive an adequate oxygen supply, which contributes to higher rates of heart attacks and strokes.
- the irritant factor is mostly “Benzo(a)pyrene”, from the tar, and when applied to ear, mouth, lungs, stomach and other organs of the animal in labor, cancer develops rapidly.
- Cigarette smoke involves both “a toxic gas phase”, and a “particulate” phase.
- Most carcinogens come from particles in tar, though a few come from gases.
- Tar containing agents that both initiate and promote cancerous changes, and co-carcinogens that, together with other with other agents form cancer-producing chemicals.
- nitrosamines polycyclic, aromatic hydrocarbons (PAHs) such as benzo(a)pyrene, and various metals (including arsenic) which cause or promote tumor growth, and it united with the hemoglobin in your blood cells and drastically reduces their capacity to carry life-giving oxygen to your cells and tissues, this causing anemia.
- PAHs aromatic hydrocarbons
- metals including arsenic
- cigarette smoke also contains other poisonous chemicals and gases, including carbolic acid, collidine, furfuralphil, appilocarpin, formaldehyde, aldehydes, formic acid, the gases include hydrogen, cyanide, nitrogen oxide, and a hefty amount of carbon monoxide.
- carbolic acid collidine
- furfuralphil furfuralphil
- appilocarpin formaldehyde
- aldehydes formic acid
- the gases include hydrogen, cyanide, nitrogen oxide, and a hefty amount of carbon monoxide.
- a number of these substances have been linked in animal and human experiments to lung and other cancers, heart and circulatory diseases, bronchitis and emphysema and powerful toxin which attack brain and nerve tissues.
- Cigarette smoking is known to alter components of the body's immune system.
- the body's immune system reacts by creating antibody to attack the following substances. This response may occur locally (at a specific organ site) or systematically (throughout the body).
- Antioxidants are indispensable organic compounds which take part in various biochemical processes. Antioxidant substances have proven to remove free radical and therefore be able to prevent chemical and spontaneous carcinogens in the epithelial tissue of the bronchi, trachea, stomach, skin, uterus and prostate in men and in animals, both in vitro and in vivo. Various mechanisms have been suggested to explain these anti-carcinogen effects and epidemiologic studies are currently testing the relationship between antioxidants and cancer in cancer patients and matched controls.
- the object of this invention is to remove free radicals and other carcinogenic ingredients to make safer to people to smoke not as safe as not smoking, but considerably safer than it is now.
- tobacco smoke filters have come into widespread use, especially for cigarettes, these currently available filters do not remove an adequate amount of the noxious substances, such as tar, nicotine, carbon monoxide, nitrous oxides, hydrogen cyanide and the like which typically lead to cancer, hearth disease or emphysema.
- noxious substances such as tar, nicotine, carbon monoxide, nitrous oxides, hydrogen cyanide and the like which typically lead to cancer, hearth disease or emphysema
- Several types of tobacco smoke filters as well as tobacco substitutes have been developed in an attempt to reduce the health hazards of tobacco smoke and at the same time allow the smoker to enjoy the pleasure of smoking tobacco.
- none of the current filters, or tobacco substitutes has proven to be effective in adequately large amounts of tar, and nicotine and noxious gases to reduce the heath hazards of tobacco smoke.
- the aim of the present invention is to develop a dual stage filter composition for tobacco smoke, mainly for cigarette smoke, which is capable to bind completely or nearly completely not only free radicals, but also the tar and other boiling health damaging materials arising from the burning of tobacco.
- the object of the present invention is achieved by compounding inert, stable and non toxic micro-powdered minerals and antioxidants, which set the stage for conducting the contemplated desired reactions such as: trapping, diffusion, interception, impaction, chelation, coupling, catalyzing the very dangerous and poisonous gas, particles and the free radicals from tobacco smoke during the process of smoking.
- One further purpose of the invention is to provide a dual device filter applicable to cigarettes, cigars, pipes or their filters and/or holders which permit to effect local filtering of carcinogenic substances according to the system outlined above.
- One object of this invention is to provide a novel tobacco filter to be inserted in a pipe, cigar, cigarette or any other tobacco smoking article loaded with antioxidants and filtering substances which aims it is to neutralize free radicals and the carcinogenic effect of the harmful ingredients in tobacco smoke.
- Another object of the invention is to provide an improved filter to be used in connection with smoking cigarettes, cigars, the like which is capable of removing a larger quantity of tars and other potentially harmful substances from the smoke, rendering the smoke entering the person's mouth relatively harmless to the person's system.
- a further object of the invention is to provide an improved filter to be used smoking tobacco, which not is capable of effectively removing harmful ingredients from the smoke, but also to cool the smoke considerably.
- the primary object of this invention has been to improve the filtering of tobacco smoke, particularly by synergistically combining absorption with the magneto-chemical treatment of the noxious components of the smoke, and control diffusion of free radicals and exerts a free radical scavenging effect.
- a tobacco smoke filter effective in removing harmful ingredients from cigarette smoke comprises:
- [0080] means to remove from tobacco smoke free radicals and other harmful ingredients, and to bring the amount of such ingredients passed by the filter down well within a tolerable limit, without significantly removing moisture from the smoke and without impairing the enjoyment of smoking, by a filter composition comprising a mixture of antioxidants and minerals divided in two stages.
- [0081] means to remove free radicals, by a first chamber ( 3 ) of the filter, inside which the smoke initially pass through, which is constituted by non absorbent antioxidants;
- [0082] means to reduce the carcinogenic substances contained in the tobacco smoke, and possible residues of antioxidants, by a second chamber ( 2 ) constituted by minerals.
- This invention relates to a new tobacco filter material useful for the removal of noxious and irritative material from tobacco smoke. More particularly, the instant invention is concerned with an improved tobacco smoke filter material comprising stable and non toxic antioxidants and mineral compositions divided in two groups.
- the first group includes antioxidants such as: Ascorbic Acid, Butylparaben, Citric Acid, Glutathione, Melatonin, Resveratrol, Selenium, Ubiquinones and Green tea.
- antioxidants such as: Ascorbic Acid, Butylparaben, Citric Acid, Glutathione, Melatonin, Resveratrol, Selenium, Ubiquinones and Green tea.
- the second group includes minerals such as: Activated Carbon, Clinoptilolite, Cuprous Chloride and Ferrite.
- the embodiments of the tobacco dual smoke filter of the present invention concern of a cylindrical tobacco smoke filter ( 1 ) assembly consisting of a tube with two chamber ( 2 , 3 ) separated from each other by a partition ( 4 ) of cellulose acetate made from a fibrous material selected from the group consisting of paper, cellulose acetate, viscose base and other types of plastics and/or metal, said tube may be embodied in a filter type cigarette (FIGS. 5 and 6) or in a holder for the cigarette (FIGS. 1 and 4), cigars, or pipe tobacco (FIG.
- said tube containing in the first chamber ( 3 ) loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion and in the second chamber ( 2 ) separated from the first one, with a cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- the nicotine, tar and all impurities such as chemical particles, melt having the consistency of a thick liquid.
- the liquefied noxious contaminants and gases including free radicals come into contact with the filter, most of them are absorbed.
- the dual filter object of this invention can absorb up to approximately 90 % of such free radicals and contaminants before the smoke is inhaled, thus producing a cleaner smoke with a very limited health detriment to the smoker.
- the synergist composition of the antioxidants and minerals object of the present invention calculated for each filter should be an amount approximately between 50 to 100 mg., then the homogenized mixture of the composition as radical scavenger and minerals as adsorbed to remove noxious particles and gases from tobacco smoke are placed between the filter separated by each other.
- Vitamin C Ascorbic Acid
- Vitamin C is often added to foods as a preservative because it interferes with oxidation. It is added to some cured meats because it inhibits the formation of nitrosamines.
- Vitamin C is a very powerful antioxidant that also protects other antioxidants, such as vitamin E.
- Vitamin C acts as a more potent free radical scavenger in the presence of a bioflavonoid called hesperidin.
- vitamin C detoxifies many harmful substances and plays a key role in immunity. It increases the synthesis of interferon, a natural antiviral substance produced by the body, and stimulates the activity of certain key immune cells.
- Butylparaben is prepared by esterification of p-hydroxybenzoic acid with butanol, small, colorless crystals or white powder. Very slightly soluble in water; freely soluble in alcohol, ether, chloroform. An antiseptic and preservative, with actions and uses similar to those of methylparaben, with which it is sometimes used in combination. It appears to be the best antifungal agent among the parabens. It is used in antiseptic creams and ointments, and in many pharmaceutical products as antioxidants.
- Butylparaben is an Antioxidant substance capable of inhibiting oxidation and that may be added for this purpose to pharmaceutical products subject to deterioration by oxidative processes as, for example, the development of rancidity in oils and fats or the inactivation of some medicinals in the environment of their dosage forms.
- oxidative is, in the common pharmaceutical sense, a substance that prevents or inhibits microbial growth and may be added to pharmaceutical preparations for this purpose to avoid consequent spoilage of the preparations by microorganisms.
- Anticoagulant Citrate Dextrose Solution Anticoagulant Citrate Phosphate Dextrose Solution, Citric Acid Syrup and effervescent salts. It also has been used to dissolve urinary bladder calculi, and as a mild astringent.
- Citric Acid is used as acidulant in beverages, confectionery, effervescent salts, in pharmaceutical syrup, elixirs, in effervescent powders and tablets, to adjust the pH of foods and as synergestic antioxidant, in processing cheese. Used in beverage, jellies, jams, preserves and candy to provide tartness. In the manufacturing resins, in esterified form as plasticizer, foam inhibitor. In the manufacturer of citric acid salts. As sequestering agent to remove trace metals. As mordant to brighten colors; in determining citrate-soluble P 2 O 5 ; as reagent for albumin, mucin, glucose, bile pigments.
- Glutathione is a protein that is produced in the liver from the amino acids cysteine, glutamic acid, and glycine. It is a powerful antioxidant that inhibits the formation of, and protects against cellular damage from, free radicals. It helps to defend the against damage from cigarette smoking exposure to radiation, cancer chemotherapy, and toxins such as alcohol. As a detoxifier of heavy metals and drugs, it aids in the treatment of blood and liver disorders.
- Glutathione protects not only individual cells but also the tissues of the arteries, brain, heart, immune cells, kidneys, lenses of the eyes, liver, lungs, and skin against oxidant damage. It plays a role in preventing cancer, especially liver cancer, and may also have an anti-aging effect. Glutathione can be taken in supplement form. The production of glutathione by the body can be boosted by taking supplemental N-acetylcysteine or L-cysteine plus L-methionine. Studies suggest that this may be a better way or rising glutathione levels than taking glutathione itself.
- Glutathione is necessary for white blood cell function and is used by the liver to help detoxify drugs. Optimal levels of gluthatione are needed for the immune defenses of the lungs: deficiencies may increase the risk of lung infections.
- the hormone melatonin may also be the most efficient free radical scavenger that has thus far been identified. While most antioxidants work only in certain parts of certain cells, melatonin can permeate any cell in any part of the body. In animal experiments, it has been shown to protect tissues from an amazing array of assaults. Within the cell, melatonin provides special protection for the nucleus the central structure that contains the DNA. Thus, it protects the structure that enables a damaged cell to repair itself. Melatonin also stimulates the enzyme glutathione peroxidase, another antioxidant.
- the hormone melatonin is naturally produced by the pineal gland, a cone-shaped structure in the brain. Throughout early life, melatonin is produced in abundance. Shortly before puberty, though, the production of melatonin begins to drop, and then continues to decline steadily as we age.
- melatonin supplements can be an effective and side-effect-free sleep aid both for adults suffering from insomnia and for children with autism, epilepsy, Down syndrome, cerebral palsy, and other problems that can cause sleep disorders.
- Animal and other laboratory research indicates that melatonin supplementation may help prevent age-related disorders, and perhaps extend life. Melatonin can be taken to ease PMS symptoms; stimulate the immune system; prevent memory loss, arteriosclerosis, and stroke; and treat cancer and Alzheimer's disease.
- Resveratrol as antioxidant was isolated from grapewines in 1976 and extensively studies for its antifungal activity and its potential use as a marker for selection of disease resistant grape cultivars.
- Resveratrol isolated from the root of the herb Polygonum Cuspidatum was found to inhibit fat deposition in the liver and improved serum chemistry in hyperlipenic rats.
- Resveratrol is a phytoalexin, in grape is readily transferred to red wine by fermentation alcohol extraction. Clinical studies showing results on heart effects of wine consumption suggesting that Resveratrol play an important role in human health.
- selenium As a component of glutathione peroxidase, and perhaps with other functions, selenium is believed by many people to protect cell membranes, prevent cardiovascular diseases, reduce the incidence of cancer, suppress arthritis, reduce aging and contribute generally to better health. It is probable that the formal recognition of selenium as a nutrient by the Food and Nutrition Board of the National Research Council (1980), their issuance of dietary guidelines for selenium, recognition of Keshan Disease in the Peoples Republic of China as a selenium deficiency disease, deficiencies of selenium in the diets of the Scandinavian countries and elsewhere may soon result in a significant portion of the world's population receiving selenium supplements. Animals already do.
- selenium is also an essential component of the antioxidant enzyme glutathione peroxidase (each molecule of this enzyme contains four atoms of selenium). This enzyme targets harmful hydrogen peroxide in the body and converts it into water. It is a particularly important guardian of the blood cells and of the heart, liver and lungs. Selenium also stimulates increased antibody response to infection.
- the recommended daily intake of selenium is 50 to 2000 micrograms.
- a group of lipid-soluble benzoquinones involved in electron transport in mitochondrial preparations i.e. in the oxidation of succinate or reduced nicotine adenine dinucleotide (NADH) via the cytochrome system. It occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.
- Ubiquinone structures analogous to the vitamin K 2 , are based on the 2,3-dimethoxy-5-methylbenzoquinone nucleus with a variable terpenoid side chain counting one to twelve mono-unsaturated trans-isoprenoid units with 10 units being the most common in animals.
- Activated carbon is capable of collecting gases, liquids, or dissolved substances on the surface of its pores.
- activated carbon Adsorption on activated carbon is selective, favoring non-polar over polar substances. Compared with other commercial absorbents, activated carbon has a broad spectrum of adsorptive activity, excellent physical and chemical stability, and ease of the production from readily available, frequently waste materials.
- any carbonaceous raw material can be used for the manufacture of activated carbon.
- Wood, peat, and lignite are commonly for the decolorizing materials.
- Nut shells (particularly coconut), coal, petroleum coke, and other residues in either granular, briqueted, or pelleted form are used for adsorbent products.
- Activation is the process of treating the carbon to open an enormous number of pores in the 1.2- to 20-nanometer-diameter range (gas-adsorbent carbon) or up to 100-mn-diameter range (decolorozing carbons). After activation, the carbon has the large surface area (500-1500 m2/g) responsible for the adsorption phenomena. Carbons that have not been subjected previously to high temperatures are easiest to activate. Selective oxidation of the base carbon with steam, carbon dioxide, fuel gas, or air is one method of developing the pore structure.
- Activated carbon is a fine, black, odorless and tasteless powder, free from gritty matter with a powerful adsorption capacity to trap, chelate, catalyze, gases and particulate matter.
- Clinoptilolite a natural occurring volcanic zeolite mineral with unique characteristics. Its chemical structure can be classified as hydrated, aluminosilicate, comprises of SiO 2 , ALO 3 , CaO, MgO, TiO 2 , Na 2 O, K 2 O, Fe 2 O 3 , MnO, arranged in interconnecting lattice structure. The arrangement of these elements in a zeolite crystal gives rise to a honeycomb framework with consistent diameter connecting channels that vary in size from 22.5 to 5.0 angstroms.
- Clinoptilolite to adsorb or catalytically remove many gases on a selective basis is in part determined by the size of the channels. Such specific channel size enables Clinoptilolite to act as molecular gas sieves and selectively adsorb and remove gases from composite gaseous mixtures such ass the ones contained in tobacco smoke. Is seemingly endless.
- Culprous chloride occurs in nature as mineral mantokite is colorless to gray, and come up as white crystal powder or cubic crystals (zinc-blend structure); stable to air and light, but in presence of moisture turns green on exposure to air and blue to brown on exposure to light.
- catalyst decolorizer and desulfuring agent in petrol industry; in denitration of cellulose; as condensing agent for soaps, fats and oils; in gas analysis to absorb carbon monoxide.
- ferrites have a crystal structure which has more than one type of site for the cations.
- the magnetic moments of the metal ions on sites of one type are parallel to each other, and antiparallel to the moments on at least one site of another type.
- ferrites exhibit ferromagnetism.
- the second class of commercially important ferrites have the garnet structure with the formula M 3 3 +Fe 3 5 +O 12 , where M 3+ is a rare-earth or yttrium ion.
- the third class of ferrites has a hexagonal structure, of the M 2 +Fe 3 12 +O 19 magneto-plumbite type, where M 2 is usually Ba, Sr, or Pb. Because of their large magnetocrystalline anisotropy, the hexagonal ferrites develop high coercivity and are an important member of the permanent magnet family.
- the present invention relates to the mineral composition which include a novel magnetized active carbon, comprising activated carbon and a magnetized ferrite powder mixed therewith, a method for reinforcing activities of active carbon using this magnetized active carbon to prevent damage caused by free radicals and from all other contaminants of tobacco smoke.
- a minerals composition comprising active carbon and a magnetized ferrite mixed therewith which is effectively used for removing free radicals, carbon monoxide, hydrogen and the like from cigarette or tobacco smoke.
- Magnetized active carbon and the other minerals of the present composition have a capacity to absorb a variety of gaseous components ranging from those having a relatively low molecular weight to those having a high molecular weight, and it shows high adsorbing capacity even when the concentration of these gaseous components is very low. Further, the activities of magnetized active carbon are scarcely influenced by humidity, and it is able to exhibit its special capacities.
- Magnetized active carbon has also catalytic effect on sulfurous acid gas, nitrogen oxides, ozone, chlorine and the like.
- the activated charcoal of the present invention has a specific surface area exceeding a million square centimeters per gram, a particle size between 8 to 50 mesh and impregnated with about 1% to 13%, preferably 4% to 6% by weight thereof of a magnetized micro-powdered ferrite in an amount not exceeding about 14% of the weight of the charcoal granules.
- Activated charcoal of gas adsorbed grade has a specific surface area in excess of 5 million square centimeters per gram and may be manufactured from coconut husk or bituminous coal.
- the particles are of such size that they will pass through a U.S. Series No. 8 sieve because larger particles are difficult to handle and to incorporate into a tobacco smoke filter cartridge but they should not pass through a U.S. Series No. 50 sieve because particles smaller than that adversely affect the draw resistance of the filter.
- Magnetized substances such as Ferrite oxide and the like are preferably incorporated in active carbon according to the present invention.
- magnetized ferromagnetic substances such as ferrite of the inverse-spinel type structure, ferrite of the probeskite structure, ferrite of the illmenite structure, ferrite of the rutile type structure and strontium ferrite.
- the removal of most of the free radicals and other harmful tobacco contaminants are accomplished by a combination of diffusion, free radicals and other impact, and direct collision of the droplets with the filter compound. Upon collision the droplets are retained on the compound by the surface attraction between the extremely small particles and the relatively large particles of the powdered compound.
- Such compound is also particularly effective for removing vaporized components from the smoke stream by the processes of physical and chemical adsorption.
- the antioxidants and the filtering substances when employed have the advantage to avoid free radicals and the toxic effects of smoking on the respiratory tract and may contain many different formulation; and it is obvious that the desired formulations may be varied in many ways and should not be limited to any theory of the invention or why it is physiologically tolerable by the smoker.
- the information given here are only by way of illustration and not by way of recommendation of smoke or to increase the quantity of tobacco to be smoked.
- FIG. 1 shows the filter at issue ( 1 ) inserted inside a cigarette holder ( 7 ) and applied to a traditional cigarette ( 8 ).
- FIG. 2 shows the filter in detail, with the two chambers ( 2 , 3 ) separated from each other by a partition of cellulose acetate ( 4 ).
- the first chamber ( 3 ) contains loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion;
- the second chamber ( 2 ), separated from the first one comprises cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- the two chambers are further isolated from the external environment at their ends by two partitions of cellulose ( 5 , 6 ), realized with the same material of the central one ( 4 ), which constitutes also the outside layer of the entire filter.
- FIG. 3 shows the exploded view of the same drawing as FIG. 2.
- FIG. 4 shows a different solution where the filter ( 1 ) is included inside a cigarette holder formed by a first part ( 7 ), containing the filter, and a second part ( 7 A) where it fits and inside which the cigarette ( 8 ) is inserted.
- FIG. 5 shows a traditional cigarette ( 8 ), which embodies the filter ( 1 ).
- FIG. 6 shows the same drawing as FIG. 5, highlighting the inside of the filter ( 1 ) embodied into the cigarette ( 8 ).
- FIG. 7 shows a pipe ( 9 ) inside which the filter ( 1 ) is inserted.
- this invention relates to a new tobacco filter material useful for the removal of noxious and irritative material from tobacco smoke. More particularly, the instant invention is concerned with an improved tobacco smoke filter material comprising stable and non toxic antioxidants and mineral compositions divided in two groups.
- the first group includes antioxidants such as: Ascorbic Acid, Butylparaben, Citric Acid, Glutathione, Melatonin, Resveratrol, Selenium, Ubiquinones and Green tea.
- the second group includes minerals such as: Activated Carbon, Clinoptilolite, Cuprous Chloride and Ferrite. All for use in such filter for the removal of noxious contaminants and free radicals from tobacco smoke.
- the embodiments of the tobacco dual smoke filter of the present invention concern of a cylindrical tobacco smoke filter ( 1 ) assembly consisting of a tube with two chamber ( 2 , 3 ) separated from each other by a partition ( 4 ) of cellulose acetate made from a fibrous material selected from the group consisting of paper, cellulose acetate, viscose base and other types of plastics and/or metal, said tube may be embodied in a filter type cigarette (FIGS. 5 and 6) or in a holder for the cigarette (FIGS. 1 and 4), cigars, or pipe tobacco (FIG.
- said tube containing in the first chamber ( 3 ) loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion and in the second chamber ( 2 ) separated from the first one, with a cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- a tobacco smoke filter effective in removing harmful ingredients from cigarette smoke comprises:
- [0197] means to remove from tobacco smoke free radicals and other harmful ingredients, and to bring the amount of such ingredients passed by the filter down well within a tolerable limit, without significantly removing moisture from the smoke and without impairing the enjoyment of smoking, by a filter composition comprising a mixture of antioxidants and minerals divided in two stages.
- [0198] means to remove free radicals, by a first chamber ( 3 ) of the filter, inside which the smoke initially pass through, which is constituted by non absorbent antioxidants;
- [0199] means to reduce the carcinogenic substances contained in the tobacco smoke, and possible residues of antioxidants, by a second chamber ( 2 ) constituted by minerals.
- FIG. 1 shows the filter at issue ( 1 ) inserted inside a cigarette holder ( 7 ) and applied to a traditional cigarette ( 8 ).
- FIG. 2 shows the filter in detail, with the two chambers ( 2 , 3 ) separated from each other by a partition of cellulose acetate ( 4 ).
- the first chamber ( 3 ) contains loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion;
- the second chamber ( 2 ), separated from the first one comprises cellulose acetate filtering material, consisting of nontoxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- the two chambers are further isolated from the external environment at their ends by two partitions of cellulose ( 5 , 6 ), realized with the same material of the central one ( 4 ), which constitutes also the outside layer of the entire filter.
- Tobacco smoke filter composition according to advantage/characteristic (“a/c”) 1, characterized by the fact that it consists of:
- Tobacco smoke filter constituted by the composition according to a/c 1, characterized by the fact that it comprises:
- Tobacco smoke filter according to a/c 1 and 3 characterized by the fact that it takes a cylindrical shape and comprises the Antioxidants and the minerals contemplated in the present synergist composition that should be, after are through mixed, introduced into the fibrous base filter in two stages, first the antioxidants ( 3 ) to be effective as free radical scavenger and than after the minerals ( 2 ) will eliminate to a significant extent the carcinogenic substance contained in the tobacco smoke.
- invention according to a/c 22, wherein it further comprises a member selected from Selenium, consisting L-Selenomethionine or L-Selenocysteine.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A tobacco smoke filter synergist composition is provided comprised of antioxidants and minerals: the former are effective as free radical scavenger and the latter are capable of reducing the other harmful substances from tobacco smoke. In particular, minerals include the magnetized ferrite, which has great adsorbing capacity. The composition can be disposed within one or more chambers.
Description
- This application is a divisional of U.S. application Ser. No. 10/085,806, filed Feb. 28, 2002, which claims the benefit of and priority to European Patent Application No. EP 01125053.7, filed Oct. 22, 2001 (both applications are incorporated by reference).
- The present invention relates to the technical sector of smoking articles and in particular of tobacco smoke filter and relative compositions to insert in cigarettes, cigars and pipes.
- Accumulated evidence by competent medical authorities indicates that the death rate from disease of the coronary arteries and the death from cancer are much higher among persons with a history of regular cigarette smoking than among persons who did not smoke. Smoke free radicals and contaminants are believed to be the primary agents in cigarette smoke hastening death to coronary artery disease. Attempts have been made to reduce the amount of smoke contaminants and other ingredients in tobacco smoke absorbed by the smoker by causing the smoke to pass through filters, which are either embodied in a filter type cigarette or in a holder for the cigarette, cigars or pipe tobacco. Such filters remove a certain proportion of smoke contaminants and tars from the smoke, but the amount remaining and passing into the smoker's system is still far greater than a safe value and is capable of causing objective damage to the lung and heart lining and other parts of the body.
- Cigarette smoking is one of the greatest public health problems in the world. Its adverse effect range from mild physical complaints (bad breath, stained fingers and teeth) to a documented decrease in life span. Smoking is known to be a contributing and perhaps the major factor in various forms of health and blood vessel disease, lung cancer, stroke, emphysema and chronic bronchitis.
- Nearly 4000 constituents of tobacco smoke have been identified: many are irritants, toxic gases or carcinogens. These particles are inhaled into the lungs, where they irritate the respiratory passages and increase the production of bronchial mucus, possibly initiating cancer.
- It is estimated that in the world ⅓ of all cancer deaths in men are related to smoking. Smoking and smokeless tobacco combine to kill more adults worldwide than any other preventable cause of death, including war, famine and terrorist attacks according to the World Watch Institute. Lung cancer cause more deaths each year than any other type of cancer. The first reports linking lung cancer to cigarette smoking were published over 40 years ago, so there is no way to claim ignorance.
- Lung cancer is one of the most difficult cancers to be treated. It is difficult to detect in its early stage, so that it often has a death grip treatment is begun. Only 13 percent of lung-cancer patients live five years or more after diagnosis. Some 85 percent of lung cancer in men is due to smoking; 75 percent of lung cancer in women is due to smoking.
- Smoking increases the risk not only of lung cancer but also of cancers of the lip, mouth, throat, larynx, esophagus, bladder, pancreas and kidney. It may be associated with cancer of the stomach and cervix, although not indirect contact with tobacco smoke are affected by the substance that the body adsorbs or metabolizes from tobacco components. The pollutants flow through the blood stream to pancreas, bladder and kidney. Unfortunately most smokers do not usually stop smoking until the onset of ill health.
- Free radicals are mentioned often in their role causing cancer, heart disease and aging. Let have a detailed look at free radicals to better understand how they cause such extensive and seemingly unrelated damage.
- As we know a free radical is an incomplete molecule. It is a fragment of a molecule that is highly reactive, because its electron arrangement is out of balance. Atoms, molecules and ions are more stable entities because they have more balanced electron arrangements.
- The highly reactive free radicals do more damage than that of one molecule to one molecule reaction. Each free radical is capable of destroying an enzyme or protein molecule or destroying an entire cell. However, the damage is much more extensive than that because each free radical usually generates a chain of free radical reactions resulting in thousands of free radicals being released to destroy body components.
- This biological magnification occurs for two reasons. The first and most important is the enormous sensitivity of the cell to modification in its heredity apparatus such as its DNA. The chromosomes, which control the reproduction of the cell, are extremely radiation sensitive; the cytoplasm is much less so. Largely, because of the sensitivity of DNA, radiations that destroy only one molecule in one million or ten million in the cell can be lethal.
- The second cause of biological magnification is that any polymeric system is sensitive to small chemical changes and many important biomolecules are polymers.
- Free radical reactions leading to cell membrane damage can cause cancer, heart disease or accelerated aging. There are five basic types of damage caused by free radicals that accelerate aging.
- 1. Lipid peroxidation, in which free radicals initiate damage to fat compounds in the body, causing them to turn rancid and release more free radicals.
- 2. Cross-linking, in which free-radical reactions cause protein and/or DNA to fuse together.
- 3. Membrane damage, in which free radical reactions destroy the integrity of the cell membrane, which in turn interferes with the cell's ability to bring in nutrients and expel wastes.
- 4. Lyposome damage, in which free-radical reactions rupture lyosome membranes, these then still into the cell and digest critical cell compounds.
- 5. Accumulation of the age pigment (lipofuscin), which may interfere with cell chemistry.
- The most damaging agents of free radical reactions including the peroxide radical (O2), hydroxyl radical (OH), lipid peroxide radical (LOO) and hydrogen peroxide (H2O2).
- The body defends itself against these agents with superoxide dismutase (an enzyme that destroys the superoxide radical), catalase (an enzyme that produces vitamin E (a general antiradical and glutathione peroxidase an enzyme that stops lipid peroxidation and converts hydrogen peroxide to water). Each molecule of glutathione peroxidase contains four atoms of selenium.
- Thus selenium is a key component of the body's defense against accelerated aging.
- Many studies have confirmed that glutathione peroxidase protects cells from mutagenic peroxides formed from DNA and nucleotides. It also breaks down lipid (fat) peroxides that can contribute to arteriosclerosis. It is also involved in the regulation of carbohydrate metabolism and in the maintenance of the integrity of red blood cells. It protects the membranes of liver-cell mitochondria (the cell's energy factors) from damage by peroxides. Glutathione peroxidase is also involved in the prostaglandin metabolism and in the killing of bacteria by white cells.
- There is evidence that free radical production increases with age. Superoxide radicals are produced by the mitochondria (energy factories) of cells. The path of superoxide radicals produced by heart mitochondria was studied and the quantity of radicals produced was measured at different ages. Eighty percent of the radicals diffused into the matrix space where they were trapped by superoxide dismutase.
- The remaining 20 percent of the superoxide radicals migrate across the mitochondria membrane into the cytosol (cell interior) where they react with various components of the mitochondrial membrane, such as polyunsaturated fatty acids.
- Researchers have found that the age-related increase in the formation of superoxide radicals is accompanied by an increase in the peroxide content of the mitochondria. Therefore, it is concluded that the free radical chain reactions appear to exceed the homeostatic protection of the mitochondria in aging animals.
- The free radicals, vapor and particles phase of smoke components of medical importance may be separated as follows:
- 1. Carcinogens and co-carcinogens are present in the tar. Carcinogens (principally polycyclic aromatic alcohols) initiate cancer formation. Co-carcinogens (including phenols, fatty acids and free fatty acids accelerate the production of cancer by other initiators. Many co-carcinogens are also irritants.
- 2. Irritants cause immediate coughing and broncho-constriction after smoke inhalation, inhibit cilial action in the bronchial epithelium, stimulate mucous secretion suppress protease inhibition and impair alveolar macrophage function.
- 3. Nicotine principally affects the nervous system and is probably responsible for a smoker's pharmacological dependence on cigarettes. Nicotine indirectly affects circulation by provoking catecholamine release which causes tachycardia, increased cardiac output, vasoconstriction and increased TB. Nicotine also increased serum free fatty acids and platelet adhesiveness and inhibits pancreatic bicarbonate secretion.
- 4. Toxic gases in cigarette smoke include CO, hydrogen sulfide, hydrocyanic acid, and oxides of nitrogen. The average carboxy-hemoglobin level in people smoking one pack/day is about 5% compared to <1% in nonsmokers. This reduced the amount of Hb available of transport and shifts to the left the Hb-dissociation curve, impairing realize to the tissues.
- 5. According to a number of literature data, the toxic, carcinogenic, mutagenic and teratogenic effects of free radicals in the human organism are considered to have been proven. A free radical is in an atom or group of atoms that contains at least one unpaired electron. Electrons are negatively charged particles that usually occur in pairs, forming a chemically stable arrangement. If an electron is unpaired, another atom or molecule can easily bond with it, causing a chemical reaction. Because they join so readily with other compounds, free radicals can effect dramatic changes in the body, and they can cause a lot of damage. Each free radical may exist for a tiny fraction of a second, but the damage it leaves behind can be irreversible.
- The presence of a dangerous number of free radicals can alter the way in which the cells code genetic material. Changes in protein structure can occur as a result of errors in protein synthesis. The body” immune system may then sere this altered protein as a foreign substance and try to destroy it. The formation of mutated proteins can eventually damage the immune system and lead to leukemia and other types of cancer, as well as a host of other diseases.
Damage Caused by Free Radicals Free Radicals Damage Superoxide Erythrocyte lysis Lung damage Degradation of human synovial fluid Singlet oxygen Eye damage Hydroxyl radicals Single and double DNA strand breaks Peroxidation of cell membranes Nitrogen dioxide Lipid peroxidation Irreversible respiratory damage Transition metals Initiate lipid peroxidation Chloroform radical Lipid peroxidation, liver damage Quinone radicals RNA, DNA damage, chemical carcinogenesis Lipid peroxidation Bipyridyl radicals formation Inhibits fatty acid synthesis, cataract Phenyldiazine radical Hemoglobin denaturation, lipid Peroxide - The diseases related to smoking are the following:
- 1. Lung cancer. Squamous cell and small (oat) cell lung carcinoma are associated. with smoking. Epidemiologic studies have shown that men who smoke more than one pack/day are about 20 times more at risk of developing lung cancer than are nonsmokers. Laboratory experiments show that condensed tobacco smoke can produce skin cancer in animals and when animals cigarette smoke may develop cancer of the larynx or lung.
- 2. Chronic bronchitis and emphysema deaths are also about 20 times more frequent in people who smoke heavily. Both diseases can be produced in animals exposed to cigarette smoke. Pulmonary function tests often show airflow obstruction in the small airways even before chronic expectation develops. The adverse effect of smoking on mucous ciliary clearance and on the normal balance between lung and protease and their inhibitors predisposes smokers to broncho-pulmonary infections and emphysema.
- 3. Cardiovascular diseases: Cigarette smoking accelerates arteriosclerosis and may double the risk of myocardial infarction. Smoking may precipitate in anginal attack or ischemic ECG changes in patients with coronary artery disease. The risk of developing disease, peripheral vascular disease, or nonsyphylitic aortic aneurysm is also increased in smokers.
- 4. Pregnancy: The mean birth weight of infants born to mothers who smoke during pregnancy is 6 oz. Less than of infants to nonsmoking mothers. The incidence of spontaneous abortion, stillbirth and neonatal death may also be increased in pregnant women who smoke.
- 5. Extra-pulmonary cancers associated with cigarette smoking include cancer of the mouth, pharynx, larynx, esophagus, bladder and pancreas.
- 6. Peptic (especially gastric) ulceration occurs more frequently and has a higher mortality rate in cigarette smokers than in non-smokers. In addition, the effectiveness of medical treatment for peptic ulceration is reduced and the rate of ulcer healing is slowed.
- 7. Other conditions: Pulmonary TB is more in smokers, perhaps due to activation of old tuberculosis foci. Tobacco amblyopia may be caused by optic nerve damage due to the toxic action of cyanides in cigarette smoke in smokers with vitamins deficiency.
- By the U.S. Surgeon General it has estimated that in the U.S. alone about 500,000 deaths are caused each year by diseases related to tobacco smoking. In fact, excessive smoking is now recognized as one of the major health problem throughout the world.
- Epidemiologists are getting better at keeping records of all this carcinogenic carnage. The body's respiratory system, for example has a well-defined local defense system. First, there are two ciliated cells with tiny hairs that line the respiratory system, the cilia prevent accumulation, if inhaled matter in the lungs by transporting the particles away from the lungs. If deciliated cells are rendered ineffective by smoke or other irritants, cells called macrophages take up their work by engulfing and digesting hazardous substances such as bacteria.
- Experiments have been able to demonstrate clearly a decreased of the cilia action due to cigarette smoking. However, it has been determined that the smokers have more macrophages in their lungs than nonsmokers, which may indicate the irritation of the cilia, perhaps in response to the free radicals and to the toxic ingredients of cigarette smoke.
- Studies of systemic immunological responses have been shown that cigarette smoking may decrease the body's production of antibodies, thus increasing its susceptibility to infection. It is true that the incidence of flu-like illness is greater among smokers of more than half a pack a day than among nonsmokers. In addition, pregnant women who smoke have more urinary tract infections than those who do not smoke.
- A long drag on a cigarette is followed by a deep inhaling that pulls the smoke down into the air passage of the lung. Black, sticky tar, with its carcinogenic chemical constituents, is deposited on the membranes of the whole bronchial system.
- Free radicals, chemicals and gases irritate the mucous membranes and damage the cilia that catch foreign matter in the passages. After years of being exposed to smoke the cilia are destroyed and the entire lung is partially or completely blackened depending on how much and how long one has smoked.
- Sooner or later, the cells lining the air passages may begin to transform because of continuous exposure to free radicals and chemical carcinogens. These cells than become irregular, clump together and over a period of years may form a growing tumor. In later stages, cancer breaks away from the lung and travels through the lymphomatic system to the organs. Metastasic tumor develops and the cancer is then usually beyond treatment. The combustion of tobacco leaves at about 1000 C. Leads to the formation of a high concentration of free radicals and a large variety of inorganic or organic gases, liquids, and solids. Ignoring side-stream smoke, i.e., that which does not pass through the cigarette, the hot mixture passes through the unburned tobacco undergoing filtration, dilution with residual gases and fresh air, and enrichment with additional vaporized materials. Looking at the existing smoke on finds that both the particle size and number concentration depends on the unburned butt length, the longer the butt, the fewer and larger the particles. This effect is apparently primarily due to the action of filtration and preferential removal of smaller particles. Fresh undiluted smoke may contain several billion of free radicals and particles per cubic centimeter of air, with droplets predominant in the 0.1 to 1.0 um diameter range and solids predominant below that size. The gaseous components in fresh smoke are to numerous to list individually. Much progress has been made in the past 30 years in the ability of scientists to identify chemicals which cause cancer.
- Cigarette smoke contains well over four thousand chemicals along with a number of unknown products and additives that are not regulated by agencies outside the tobacco industry (nor obviously by anyone within it). They may include pesticides (used to protect the tobacco plants from bugs), some of which have not been tested for safety.
- Many of these chemicals are produced in tiny concentrations, and they may only exist in an active form for seconds before the body detoxifies them. This makes them virtually impossible to study. Despite their small amounts and transient presence, smoking is an efficient and rapid way to inject these chemicals into the lungs and the bloodstream, representing a significant risk to health in general and to lung cancer specifically. In turning toward chemicals produced by burning tobacco, one probable culprit definitely worth discussion is carbon monoxide, the same poison found in abundance in automobile exhaust. It reacts with a molecule called hemoglobin and hinders red cells' ability to carry oxygen to the heart, brain and other vital organs. The heart is called upon the deliver more blood quickly to make up for this oxygen deficit, even as its own needs are unmet. Even more serious is the fact that insufficient oxygen soon causes cells to die. Evidence of this phenomenon is all too common in autopsies of heart attack victims.
- Cigarette smoking contains 2 percent to 6 percent carbon monoxide. Everyone living in the industrialized world loose some hemoglobin to carbon monoxide found in the air. However, while the average loss in nonsmokers is 1 percent, smokers lose up 15 percent. This means that smokers run a much higher risk that vital organs will not receive an adequate oxygen supply, which contributes to higher rates of heart attacks and strokes.
- When tobacco is smoked, tar results, which enter into lungs, irritate the delicate cells as dangerous as a chimney soot. From a pack of cigarette a day smokers absorb eight hundred and forty cubic centimeters of tobacco tar in a year. We have known about the tar problem for a long time. Back in 1953, Dr. Ernst Wynders and his colleagues at the Memorial Sloan-Kettering Cancer Center in Manhattan showed a direct cause and effect relationship between the tar of cigarette smoke and malignant tumor. The backs of mice were painted with the tar extract of tobacco smoke, and 44 percent of the animals developed malignant skin cancer.
- The irritant factor is mostly “Benzo(a)pyrene”, from the tar, and when applied to ear, mouth, lungs, stomach and other organs of the animal in labor, cancer develops rapidly. Cigarette smoke involves both “a toxic gas phase”, and a “particulate” phase. Most carcinogens come from particles in tar, though a few come from gases. Tar containing agents that both initiate and promote cancerous changes, and co-carcinogens that, together with other with other agents form cancer-producing chemicals. There are nitrosamines, polycyclic, aromatic hydrocarbons (PAHs) such as benzo(a)pyrene, and various metals (including arsenic) which cause or promote tumor growth, and it united with the hemoglobin in your blood cells and drastically reduces their capacity to carry life-giving oxygen to your cells and tissues, this causing anemia.
- As this cornucopia of carcinogens was not enough, cigarette smoke also contains other poisonous chemicals and gases, including carbolic acid, collidine, furfuralphil, appilocarpin, formaldehyde, aldehydes, formic acid, the gases include hydrogen, cyanide, nitrogen oxide, and a hefty amount of carbon monoxide. A number of these substances have been linked in animal and human experiments to lung and other cancers, heart and circulatory diseases, bronchitis and emphysema and powerful toxin which attack brain and nerve tissues.
- When smoking, tobacco combustion develops with an inordinately large number of free radicals, these poisons are inhaled into the lungs where are absorbed by the millions of tiny vessels lining the lungs. They are transformed by the bloodstream, which carries them to every cell and tissue in your body, even if you do not inhale. Pipes and cigars smokers may also be affected by malignant tissue on the tongue or lips.
- Sooner or later smokers develop a cough, the first symptoms of the lung cancer. Many pay no attention. The heartbeat and pulse as well as the blood pressure, increase smokers with normal blood pressure of one hundred and fifty, smoking might push it up to two hundred and seven. Heading the list of results are these: brain strokes, along with heart attacks and coronary thromboses. There is scarcely a single bodily function which is not impaired by smoking. Other results included: acid indigestion, flatulence, nausea, belching, ulcers, allergies, asthma and bronchitis.
- Consequently the consensus of everyone from the Surgeon General and National Academy of Science to the American Cancer is that there is no safe cigarette.
- Cigarette smoking is known to alter components of the body's immune system. When the body is invaded by a substance that is recognized as “Foreign” the body's immune system reacts by creating antibody to attack the following substances. This response may occur locally (at a specific organ site) or systematically (throughout the body).
- Attempts to remove the free radicals and the carcinogenic materials found in the smoke tobacco, have not been successful enough to bring a safer smoking articles to the public market, since no adequate filtering means has not yet been invented, which can effectively remove free radicals and the carcinogenic substances without simultaneously removing most part of the desirable aroma and taste of the smoking articles.
- Antioxidants are indispensable organic compounds which take part in various biochemical processes. Antioxidant substances have proven to remove free radical and therefore be able to prevent chemical and spontaneous carcinogens in the epithelial tissue of the bronchi, trachea, stomach, skin, uterus and prostate in men and in animals, both in vitro and in vivo. Various mechanisms have been suggested to explain these anti-carcinogen effects and epidemiologic studies are currently testing the relationship between antioxidants and cancer in cancer patients and matched controls.
- Ever since it has been universally recognized that the smoke combustion of tobacco produces carcinogens that cannot be satisfactory filtered out without destroying the pleasure of smoking, there has been a need as cancer prevention for a safe cigarette filter containing antioxidants and other filtering substances, which insure the removal of free radicals and other carcinogenic substances, at a controlled rate and continuously during the entire process, preventing smoke related diseases into the respiratory tract of the smoke.
- Therefore, the object of this invention is to remove free radicals and other carcinogenic ingredients to make safer to people to smoke not as safe as not smoking, but considerably safer than it is now.
- Let's consider why people continue to smoke. They don't quit because smoking gives them certain benefits. Many campaigners for the elimination of cigarette smoking have not realized that people would lose these benefits, as well as the health risks. Tobacco has significant effects on behavior and psychological state. Recent research has shown that cigarette smokers (and other who use tobacco) find that tobacco use makes it easier to cope with over-stimulation like city noise and overcrowding. That's because the nicotine in cigarette smoke is a stimulation barrier, a substance that makes it easier for a person to function in an over-stimulating environment.
- Although tobacco smoke filters have come into widespread use, especially for cigarettes, these currently available filters do not remove an adequate amount of the noxious substances, such as tar, nicotine, carbon monoxide, nitrous oxides, hydrogen cyanide and the like which typically lead to cancer, hearth disease or emphysema, Several types of tobacco smoke filters as well as tobacco substitutes have been developed in an attempt to reduce the health hazards of tobacco smoke and at the same time allow the smoker to enjoy the pleasure of smoking tobacco. However, none of the current filters, or tobacco substitutes has proven to be effective in adequately large amounts of tar, and nicotine and noxious gases to reduce the heath hazards of tobacco smoke.
- The commonly utilized cigarette filter available on the market removes from tobacco smoke only a fraction of the carcinogenic constituents present within, allowing most of the droplets passing through it.
- It can be stated from the literature that a high number of processes are worldwide known which suggest methods for the filtration of the tobacco smoke. It can also be stated from the literature that a high number of processes are worldwide known which suggest methods for the filtration of the tobacco smoke. It can also be stated that, in spite of the very high number of data concerning this subject, no conscious, conceptional method exists for the contaminants released in the burning and being present in the tobacco smoke which, as it is commonly known, arises from a high-temperature burning.
- Nowadays, innumerable processes used for filtering tobacco smoke are known. A great number of publications have been devoted to the additives of the smoke filters. These additives in the smoke filter are aimed to absorb and/or absorb a certain ratio of the harmful components of cigarette smoke according to the eventual physical and/or physico-chemical relationships coming about between the constituents of the smoke filter and the components being present in the tobacco smoke.
- A plethora of patented processes are particularly found under the collective noun of “substances binding and filtering out carcinogenic smoke components”.
- Through my scientific research, we now know why people smoke, what real psychological and behavioral benefits smoking provides, what the major molecular mechanisms are which make smoking hazardous, and finally, how to reduce the hazards of smoking without reducing those benefits of smoking pleasure.
- The aim of the present invention is to develop a dual stage filter composition for tobacco smoke, mainly for cigarette smoke, which is capable to bind completely or nearly completely not only free radicals, but also the tar and other boiling health damaging materials arising from the burning of tobacco.
- The object of the present invention is achieved by compounding inert, stable and non toxic micro-powdered minerals and antioxidants, which set the stage for conducting the contemplated desired reactions such as: trapping, diffusion, interception, impaction, chelation, coupling, catalyzing the very dangerous and poisonous gas, particles and the free radicals from tobacco smoke during the process of smoking.
- In accordance with the present invention the compound disclosed herein is effective in reducing considerably the amount of free radicals, and many other harmful smoke constituents, which are not limited to: acetaldehyde, acetone, acrolein, acrylonitrile, ammonia, 4-amino-biphenyl, benzene, 1-3 butadiene, butyraldehyde, cadmium, carbon monoxide, catechol, crotonaldehyde, formaldehyde, hydrogen cyanide, hydrogen selenide, lead, m, p and o-cresol, mercury, methyl ethyl ketone, nickel, n-nitrosamines, nitric oxide, p-hydroquinone, phenol, propionaldehyde, quinoline, styrene, tar, toluene, etc.
- One further purpose of the invention is to provide a dual device filter applicable to cigarettes, cigars, pipes or their filters and/or holders which permit to effect local filtering of carcinogenic substances according to the system outlined above.
- One object of this invention is to provide a novel tobacco filter to be inserted in a pipe, cigar, cigarette or any other tobacco smoking article loaded with antioxidants and filtering substances which aims it is to neutralize free radicals and the carcinogenic effect of the harmful ingredients in tobacco smoke.
- Accordingly, it is an object of the present invention to provide filter to be used by persons smoking tobacco, which is capable of reducing the amount of contaminants in the smoking passing to the person's mouth to a safe value.
- Another object of the invention is to provide an improved filter to be used in connection with smoking cigarettes, cigars, the like which is capable of removing a larger quantity of tars and other potentially harmful substances from the smoke, rendering the smoke entering the person's mouth relatively harmless to the person's system.
- A further object of the invention is to provide an improved filter to be used smoking tobacco, which not is capable of effectively removing harmful ingredients from the smoke, but also to cool the smoke considerably.
- The primary object of this invention has been to improve the filtering of tobacco smoke, particularly by synergistically combining absorption with the magneto-chemical treatment of the noxious components of the smoke, and control diffusion of free radicals and exerts a free radical scavenging effect.
- Reduced to its essential structure and with reference to the figures of the enclosed drawings, a tobacco smoke filter effective in removing harmful ingredients from cigarette smoke, comprises:
- means to remove from tobacco smoke free radicals and other harmful ingredients, and to bring the amount of such ingredients passed by the filter down well within a tolerable limit, without significantly removing moisture from the smoke and without impairing the enjoyment of smoking, by a filter composition comprising a mixture of antioxidants and minerals divided in two stages.
- means to remove free radicals, by a first chamber (3) of the filter, inside which the smoke initially pass through, which is constituted by non absorbent antioxidants;
- means to reduce the carcinogenic substances contained in the tobacco smoke, and possible residues of antioxidants, by a second chamber (2) constituted by minerals.
- This invention relates to a new tobacco filter material useful for the removal of noxious and irritative material from tobacco smoke. More particularly, the instant invention is concerned with an improved tobacco smoke filter material comprising stable and non toxic antioxidants and mineral compositions divided in two groups.
- The first group includes antioxidants such as: Ascorbic Acid, Butylparaben, Citric Acid, Glutathione, Melatonin, Resveratrol, Selenium, Ubiquinones and Green tea.
- The second group includes minerals such as: Activated Carbon, Clinoptilolite, Cuprous Chloride and Ferrite.
- All for use in such filter for the removal of noxious contaminants and free radicals from tobacco smoke.
- The embodiments of the tobacco dual smoke filter of the present invention concern of a cylindrical tobacco smoke filter (1) assembly consisting of a tube with two chamber (2, 3) separated from each other by a partition (4) of cellulose acetate made from a fibrous material selected from the group consisting of paper, cellulose acetate, viscose base and other types of plastics and/or metal, said tube may be embodied in a filter type cigarette (FIGS. 5 and 6) or in a holder for the cigarette (FIGS. 1 and 4), cigars, or pipe tobacco (FIG. 7), which such porosity to permit the passage of smoke through, said tube containing in the first chamber (3) loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion and in the second chamber (2) separated from the first one, with a cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- During smoking the combination of the high temperature and created suction force, the nicotine, tar and all impurities such as chemical particles, melt having the consistency of a thick liquid. As the liquefied noxious contaminants and gases including free radicals come into contact with the filter, most of them are absorbed.
- The scope to have antioxidants in a separate chamber is due to the fact if for some unknown chamber is due to the fact if for some unknown reason, the high temperature of the tobacco smoke will melt even a small fraction of the antioxidants the same will be removed completely by the mineral compound positioned in the second chamber.
- The dual filter object of this invention can absorb up to approximately90% of such free radicals and contaminants before the smoke is inhaled, thus producing a cleaner smoke with a very limited health detriment to the smoker.
- The synergist composition of the antioxidants and minerals object of the present invention calculated for each filter (in one cigarette, one cigar or a pipe) should be an amount approximately between 50 to 100 mg., then the homogenized mixture of the composition as radical scavenger and minerals as adsorbed to remove noxious particles and gases from tobacco smoke are placed between the filter separated by each other.
- Hereby is the list of the Antioxidants and Minerals object of the present invention but such list should not be limited to the following:
- Vitamin C (Ascorbic Acid)
- The story of vitamin C begins centuries before the discovery of the vitamin, with accounts of a disease call scurvy.
- Scurvy an ailment characterized by muscle weakness, lethargy and bleeding under the skin has been rampant around the world throughout the centuries. Documents written before the birth of Christ describe the disease. Almost as old as the reports of the disease are the reports of successful ways of treating it. The discovery of the cure for scurvy marked the end of one chapter in the story of vitamin C.
- Vitamin C is often added to foods as a preservative because it interferes with oxidation. It is added to some cured meats because it inhibits the formation of nitrosamines.
- Vitamin C is a very powerful antioxidant that also protects other antioxidants, such as vitamin E. The cells of the brain and spinal cord, which frequently incur free radical damage, can be protected by significant amount of vitamin C. Vitamin C acts as a more potent free radical scavenger in the presence of a bioflavonoid called hesperidin.
- In addition to its role as an antioxidant, vitamin C detoxifies many harmful substances and plays a key role in immunity. It increases the synthesis of interferon, a natural antiviral substance produced by the body, and stimulates the activity of certain key immune cells.
- Butylparaben
- Butylparaben is prepared by esterification of p-hydroxybenzoic acid with butanol, small, colorless crystals or white powder. Very slightly soluble in water; freely soluble in alcohol, ether, chloroform. An antiseptic and preservative, with actions and uses similar to those of methylparaben, with which it is sometimes used in combination. It appears to be the best antifungal agent among the parabens. It is used in antiseptic creams and ointments, and in many pharmaceutical products as antioxidants.
- Butylparaben is an Antioxidant substance capable of inhibiting oxidation and that may be added for this purpose to pharmaceutical products subject to deterioration by oxidative processes as, for example, the development of rancidity in oils and fats or the inactivation of some medicinals in the environment of their dosage forms. As preservative is, in the common pharmaceutical sense, a substance that prevents or inhibits microbial growth and may be added to pharmaceutical preparations for this purpose to avoid consequent spoilage of the preparations by microorganisms.
- Citric Acid
- It's found in many plants. It formerly was obtained solely from the juice of limes and lemons and from pineapple wastes. Since about 1925 the acid has been produced largely by fermentation of sucrose solution, including molasses, by fungi belonging to theApergillus niger group, theoretically according to the following reactions: C12H22O11 (Sucrose)+302 (Oxygen)>2H3C6H5O7 (Citric Acid)+3H2O (Water). But in practice there are deviations from this stoichiometric relationship.
- Colorless, translucent crystals, or a white, granular to fine crystalline powder; odorless; strongly acid taste; the hydrous form effloresces in moderate dry air, but is slightly deliquescent in moist air; are subject to molding (fermentation), oxalic acid being one of the fermentation products.
- In the preparation of Anticoagulant Citrate Dextrose Solution, Anticoagulant Citrate Phosphate Dextrose Solution, Citric Acid Syrup and effervescent salts. It also has been used to dissolve urinary bladder calculi, and as a mild astringent.
- Citric Acid is used as acidulant in beverages, confectionery, effervescent salts, in pharmaceutical syrup, elixirs, in effervescent powders and tablets, to adjust the pH of foods and as synergestic antioxidant, in processing cheese. Used in beverage, jellies, jams, preserves and candy to provide tartness. In the manufacturing resins, in esterified form as plasticizer, foam inhibitor. In the manufacturer of citric acid salts. As sequestering agent to remove trace metals. As mordant to brighten colors; in determining citrate-soluble P2O5; as reagent for albumin, mucin, glucose, bile pigments.
- Glutathione
- Glutathione is a protein that is produced in the liver from the amino acids cysteine, glutamic acid, and glycine. It is a powerful antioxidant that inhibits the formation of, and protects against cellular damage from, free radicals. It helps to defend the against damage from cigarette smoking exposure to radiation, cancer chemotherapy, and toxins such as alcohol. As a detoxifier of heavy metals and drugs, it aids in the treatment of blood and liver disorders.
- Glutathione protects cells in several ways. It neutralizes oxygen molecules before they can harm cells. Together with selenium, it forms the enzyme glutathione peroxides, which neutralize hydrogen peroxides. It is also a component of another antioxidant enzyme, glutathione-s-transferase, which is a broad-spectrum liver-detoxyfying enzyme.
- Glutathione protects not only individual cells but also the tissues of the arteries, brain, heart, immune cells, kidneys, lenses of the eyes, liver, lungs, and skin against oxidant damage. It plays a role in preventing cancer, especially liver cancer, and may also have an anti-aging effect. Glutathione can be taken in supplement form. The production of glutathione by the body can be boosted by taking supplemental N-acetylcysteine or L-cysteine plus L-methionine. Studies suggest that this may be a better way or rising glutathione levels than taking glutathione itself.
- Glutathione is necessary for white blood cell function and is used by the liver to help detoxify drugs. Optimal levels of gluthatione are needed for the immune defenses of the lungs: deficiencies may increase the risk of lung infections.
- Melatonin
- Among the newest antioxidants to be discovered, the hormone melatonin may also be the most efficient free radical scavenger that has thus far been identified. While most antioxidants work only in certain parts of certain cells, melatonin can permeate any cell in any part of the body. In animal experiments, it has been shown to protect tissues from an amazing array of assaults. Within the cell, melatonin provides special protection for the nucleus the central structure that contains the DNA. Thus, it protects the structure that enables a damaged cell to repair itself. Melatonin also stimulates the enzyme glutathione peroxidase, another antioxidant.
- The hormone melatonin is naturally produced by the pineal gland, a cone-shaped structure in the brain. Throughout early life, melatonin is produced in abundance. Shortly before puberty, though, the production of melatonin begins to drop, and then continues to decline steadily as we age.
- Research has demonstrated that melatonin may have several profound long-term effects on the body. As one of the most powerful antioxidants ever discovered with a greater range of effectiveness than vitamin C, vitamin E, or beta-carotene, melatonin helps prevent harmful oxidation reactions from occurring. In this way, melatonin may prevent the change that lead to hypertension and heart attack, and may reduce the risk of certain kinds of cancer. Indeed, research has indicated that many age-related problems are caused by declining levels of melatonin, which leave the body less able to prevent and repair oxidative damage. Melatonin also has been found to stimulate the immune system; have a major role in the production of estrogen, testosterone, and possibly other hormones, helping to prevent cancers involving the reproductive system; and slow the growth of existing malignancies.
- Recent studies suggest that if melatonin is taken in the mornings, tumor growth may be stimulated, but if it is taken in the evenings, it has a retarding effect on tumor growth. In addition, as melatonin is secreted clinically, in response to the fall of darkness at the end of each day, the hormone helps our body keep in sync with the rhythms of day and night. Thus, melatonin helps regulate sleep.
- Research on melatonin continues, and with it, knowledge is increasing about the functions of melatonin in the body and the effects of melatoni supplementation. Both human research studies and anecdotal evidence indicate that melatonin supplements can be an effective and side-effect-free sleep aid both for adults suffering from insomnia and for children with autism, epilepsy, Down syndrome, cerebral palsy, and other problems that can cause sleep disorders. Animal and other laboratory research indicates that melatonin supplementation may help prevent age-related disorders, and perhaps extend life. Melatonin can be taken to ease PMS symptoms; stimulate the immune system; prevent memory loss, arteriosclerosis, and stroke; and treat cancer and Alzheimer's disease.
- Resveratrol
- In Europe, Resveratrol as antioxidant was isolated from grapewines in 1976 and extensively studies for its antifungal activity and its potential use as a marker for selection of disease resistant grape cultivars.
- Instead in China and in Japan, Resveratrol has been extensively studied not for its role in the plant's defense against diseases, but as active ingredient of several traditional medicines used for centuries.
- In Japan, Resveratrol isolated from the root of the herb Polygonum Cuspidatum (Polygonaceae) was found to inhibit fat deposition in the liver and improved serum chemistry in hyperlipenic rats. In addition Resveratrol demonstrated as variety of pharmaceutical effects in mammalian in vitro and in vivo studies.
- Resveratrol is a phytoalexin, in grape is readily transferred to red wine by fermentation alcohol extraction. Clinical studies showing results on heart effects of wine consumption suggesting that Resveratrol play an important role in human health.
- Selenium
- Selenium was named for the goddess of the moon, Selene; but for nutrition it has been a shining star of the last decade. Nor since the recognition of the mineral cobalt as part of vitamin B-12 in the mid 1950s has a mineral been recognized as having a precisely definable function in human or animal nutrition has happened with selenium. In 1973, Dr. J. T. Rotruck (then at the University of Wisconsin) and his associates identified selenium as a necessary component of an enzyme, glutathione peroxidase.
- As a component of glutathione peroxidase, and perhaps with other functions, selenium is believed by many people to protect cell membranes, prevent cardiovascular diseases, reduce the incidence of cancer, suppress arthritis, reduce aging and contribute generally to better health. It is probable that the formal recognition of selenium as a nutrient by the Food and Nutrition Board of the National Research Council (1980), their issuance of dietary guidelines for selenium, recognition of Keshan Disease in the Peoples Republic of China as a selenium deficiency disease, deficiencies of selenium in the diets of the Scandinavian countries and elsewhere may soon result in a significant portion of the world's population receiving selenium supplements. Animals already do.
- A partner and synergist with vitamin E, selenium is also an essential component of the antioxidant enzyme glutathione peroxidase (each molecule of this enzyme contains four atoms of selenium). This enzyme targets harmful hydrogen peroxide in the body and converts it into water. It is a particularly important guardian of the blood cells and of the heart, liver and lungs. Selenium also stimulates increased antibody response to infection. Some important facts about selenium include:
- Selenium's relationship to human health is an established fact.
- The recommended daily intake of selenium is 50 to 2000 micrograms.
- Several high regarded scientists have state that millions of Americans receive less than optimum amounts of selenium in their diets
- Many people live in areas with low soil selenium availability.
- Selenium can help prevent many forms of cancer.
- Selenium can help protect against heart disease.
- Selenium strengthens your immune system.
- Selenium may improve your energy level.
- Selenium helps prevent or relieve arthritis.
- Selenium can slow down evidence of aging and help make you look younger.
- Selenium detoxifies several heavy metal pollutants including cadmium, mercury and probably lead.
- Selenium may prevent the onset of cataracts.
- Selenium may affect fertility, sex drive and human reproduction.
- Ubiquinones
- A group of lipid-soluble benzoquinones involved in electron transport in mitochondrial preparations, i.e. in the oxidation of succinate or reduced nicotine adenine dinucleotide (NADH) via the cytochrome system. It occurs in the majority of aerobic organisms, from bacteria to higher plants and animals. Ubiquinone structures, analogous to the vitamin K2, are based on the 2,3-dimethoxy-5-methylbenzoquinone nucleus with a variable terpenoid side chain counting one to twelve mono-unsaturated trans-isoprenoid units with 10 units being the most common in animals. According to the existing dual system of nomenclature the compounds can be described as: coenzyme Qn in which n=1-12, or ubiquinone(x) in which x designates the total number of carbon atoms in the side chain and can be any multiple of 5. Differences in properties are due to the difference in length of the side chain. Naturally occurring members are the coenzymes Q6-Q10.
- Activated Carbon
- A powdered, granular or pelleted form of amorphous carbon characterized by very large surface area per unit volume because of an enormous number of fine pores. Activated carbon is capable of collecting gases, liquids, or dissolved substances on the surface of its pores.
- Adsorption on activated carbon is selective, favoring non-polar over polar substances. Compared with other commercial absorbents, activated carbon has a broad spectrum of adsorptive activity, excellent physical and chemical stability, and ease of the production from readily available, frequently waste materials.
- Almost any carbonaceous raw material can be used for the manufacture of activated carbon. Wood, peat, and lignite are commonly for the decolorizing materials. Nut shells (particularly coconut), coal, petroleum coke, and other residues in either granular, briqueted, or pelleted form are used for adsorbent products.
- Activation is the process of treating the carbon to open an enormous number of pores in the 1.2- to 20-nanometer-diameter range (gas-adsorbent carbon) or up to 100-mn-diameter range (decolorozing carbons). After activation, the carbon has the large surface area (500-1500 m2/g) responsible for the adsorption phenomena. Carbons that have not been subjected previously to high temperatures are easiest to activate. Selective oxidation of the base carbon with steam, carbon dioxide, fuel gas, or air is one method of developing the pore structure.
- Activated carbon is a fine, black, odorless and tasteless powder, free from gritty matter with a powerful adsorption capacity to trap, chelate, catalyze, gases and particulate matter.
- Clinoptilolite
- Clinoptilolite, a natural occurring volcanic zeolite mineral with unique characteristics. Its chemical structure can be classified as hydrated, aluminosilicate, comprises of SiO2, ALO3, CaO, MgO, TiO2, Na2O, K2O, Fe2O3, MnO, arranged in interconnecting lattice structure. The arrangement of these elements in a zeolite crystal gives rise to a honeycomb framework with consistent diameter connecting channels that vary in size from 22.5 to 5.0 angstroms.
- This unique structure makes Clinoptililite different from other Aluminum Silicates (zeolite, kaolin, bentonite, etc.) due to its extraordinary gas adsorption properties.
- The ability of Clinoptilolite to adsorb or catalytically remove many gases on a selective basis is in part determined by the size of the channels. Such specific channel size enables Clinoptilolite to act as molecular gas sieves and selectively adsorb and remove gases from composite gaseous mixtures such ass the ones contained in tobacco smoke. Is seemingly endless.
- The following list depicts just few of those gases on which Clinoptililite are currently known to have an effect on their elimination or containment:
- Co, Co2, SO2, H2S, NH3, HCHO, Ar, O2, N2, H2O, He, H2,
- Kr, Xe, CH3OH, Freon, Formaldehyde, etc.
- Cuprous Chloride
- Culprous chloride occurs in nature as mineral mantokite is colorless to gray, and come up as white crystal powder or cubic crystals (zinc-blend structure); stable to air and light, but in presence of moisture turns green on exposure to air and blue to brown on exposure to light.
- Sparingly soluble in water with partial decomposition, practically insoluble in alcohol, acetone, hydrochloric acid and other formation of complexes.
- As catalyst for organic reactions; catalyst decolorizer and desulfuring agent in petrol industry; in denitration of cellulose; as condensing agent for soaps, fats and oils; in gas analysis to absorb carbon monoxide.
- Ferrite
- Any of the class of magnetic oxides. Typically the ferrites have a crystal structure which has more than one type of site for the cations. Usually the magnetic moments of the metal ions on sites of one type are parallel to each other, and antiparallel to the moments on at least one site of another type. Thus ferrites exhibit ferromagnetism.
- There are three important classes of commercial ferrites:
- One class has the spinel structure, with the general formula M2+Fe2 3++O4, where M2+ is a divalent metal ion. So-called linear ferrites used in inductors and transformers are made of Mn and Zn (for frequencies up to 1<MHz) and Ni and Zn (for frequencies greater that 1 MHz) and Ni and Zn (for frequencies greater that 1 MHz). MgMn ferrites are used in microwave devices such as isolators and circulators.
- The second class of commercially important ferrites have the garnet structure with the formula M3 3+Fe3 5+O12, where M3+ is a rare-earth or yttrium ion.
- The third class of ferrites has a hexagonal structure, of the M2+Fe3 12+O19 magneto-plumbite type, where M2 is usually Ba, Sr, or Pb. Because of their large magnetocrystalline anisotropy, the hexagonal ferrites develop high coercivity and are an important member of the permanent magnet family.
- Another magnetic oxide, y-Fe2O3 also has the spinel structure, but has no divalent cations. It is the most commonly used material in the preparation of magnetic recording tapes.
- The largest usage of ferrite measured in terms of material weight is in the nonlinear B/h range, and is found in the form if deflecting yokes and flyback transformers for television receivers.
- In details the present invention relates to the mineral composition which include a novel magnetized active carbon, comprising activated carbon and a magnetized ferrite powder mixed therewith, a method for reinforcing activities of active carbon using this magnetized active carbon to prevent damage caused by free radicals and from all other contaminants of tobacco smoke.
- The present invention has been completed as a result of research work made with a view to highly reinforcing activities of magnetized active carbon such as adsorbing catalytic free radical scavenging capabilities and substantially increase the effectiveness of the filter reducing the content of noxious materials in the tobacco smoke, while leaving the drawing quality unimpaired.
- According to another aspect of the present invention there is provided a minerals composition comprising active carbon and a magnetized ferrite mixed therewith which is effectively used for removing free radicals, carbon monoxide, hydrogen and the like from cigarette or tobacco smoke.
- Magnetized active carbon and the other minerals of the present composition have a capacity to absorb a variety of gaseous components ranging from those having a relatively low molecular weight to those having a high molecular weight, and it shows high adsorbing capacity even when the concentration of these gaseous components is very low. Further, the activities of magnetized active carbon are scarcely influenced by humidity, and it is able to exhibit its special capacities.
- Magnetized active carbon has also catalytic effect on sulfurous acid gas, nitrogen oxides, ozone, chlorine and the like.
- The activated charcoal of the present invention has a specific surface area exceeding a million square centimeters per gram, a particle size between 8 to 50 mesh and impregnated with about 1% to 13%, preferably 4% to 6% by weight thereof of a magnetized micro-powdered ferrite in an amount not exceeding about 14% of the weight of the charcoal granules.
- Activated charcoal of gas adsorbed grade has a specific surface area in excess of 5 million square centimeters per gram and may be manufactured from coconut husk or bituminous coal. The particles are of such size that they will pass through a U.S. Series No. 8 sieve because larger particles are difficult to handle and to incorporate into a tobacco smoke filter cartridge but they should not pass through a U.S. Series No. 50 sieve because particles smaller than that adversely affect the draw resistance of the filter.
- Magnetized substances such as Ferrite oxide and the like are preferably incorporated in active carbon according to the present invention. In general, there may also be employed magnetized ferromagnetic substances such as ferrite of the inverse-spinel type structure, ferrite of the probeskite structure, ferrite of the illmenite structure, ferrite of the rutile type structure and strontium ferrite.
- According to the laboratory test on the formulation of the present invention confirm that the carcinogenic substance content of the tobacco smoke will be diminished by the synergetic effect of the various types of ingredients of the formulation.
- This has also been proved by experiments, namely, when the tobacco smoke condense was introduced into a solution containing the composition of the present invention, the phenomenon of the free radical development by tobacco burning, were considerably decreased or eliminated to a significant extent. It is obvious that not only harmful contaminants free radicals were removed but also many dangerous contaminants.
- However the laboratory experiments carried out on the basis of this invention lead to the surprising unexpected result that the formulation considerably decrease the amount of free radicals and remove deleterious carcinogenic substances arises from tobacco high-temperature burning.
- The Antioxidants and the mineral contemplated in the present synergist composition should be, after are through mixed, introduced into the fibrous base filter in two stages, first the antioxidants to be effective as free radical scavenger and than after the minerals will eliminate to a significant extent the carcinogenic substance contained in the tobacco smoke.
- The ingredients of the tobacco smoke filter of the present composition due to the mutual strengthening effect on each other, such synergistic achievement is capable to bind and to remove up to nearly 90% of the free radicals and 75% of the other dangerous contaminants of tobacco smoke.
- In the present filter compound, the removal of most of the free radicals and other harmful tobacco contaminants are accomplished by a combination of diffusion, free radicals and other impact, and direct collision of the droplets with the filter compound. Upon collision the droplets are retained on the compound by the surface attraction between the extremely small particles and the relatively large particles of the powdered compound. Such compound is also particularly effective for removing vaporized components from the smoke stream by the processes of physical and chemical adsorption.
- It is furthermore to be noted that in addition to the direct reduction of the total amount of combustion gases drawn from tobacco, there occurs still a further effect, namely, that of decreasing toxicity.
- When tobacco smoke passes into the filter, large quantities of tar, nicotine and other noxious substances are absorbed by the filter and will fail to reach the smoker, with the result to significantly reducing the hazards of smoking tobacco.
- The antioxidants and the filtering substances, when employed have the advantage to avoid free radicals and the toxic effects of smoking on the respiratory tract and may contain many different formulation; and it is obvious that the desired formulations may be varied in many ways and should not be limited to any theory of the invention or why it is physiologically tolerable by the smoker. The information given here are only by way of illustration and not by way of recommendation of smoke or to increase the quantity of tobacco to be smoked.
- Having not fully described this invention, it will be appreciated by those skilled in the art that the same can be performed with a wide range of concentrations without departing from the spirit and scope of the invention.
- When the invention has been described and disclosed in certain terms and has been illustrated by disclosure of certain embodiments or modifications, persons skilled in the art who have acquainted themselves with the invention will appreciate that it is not necessarily limited by such terms nor to the specific embodiments and modifications disclosed herein. Thus, a wide variety of alternatives, suggested by the teachings herein, can be practiced without departing from the spirit of the invention, and rights to such alternatives are particularly reserved, especially those which fall within the scope of appended claims.
- These and further characteristics of the present invention can be better understood by every expert in this field by reading the following description and referring to the enclosed drawings, given as practical examples of the invention, but not to be considered restrictive.
- FIG. 1 shows the filter at issue (1) inserted inside a cigarette holder (7) and applied to a traditional cigarette (8).
- FIG. 2 shows the filter in detail, with the two chambers (2, 3) separated from each other by a partition of cellulose acetate (4). The first chamber (3) contains loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion; the second chamber (2), separated from the first one, comprises cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke. The two chambers are further isolated from the external environment at their ends by two partitions of cellulose (5, 6), realized with the same material of the central one (4), which constitutes also the outside layer of the entire filter.
- FIG. 3 shows the exploded view of the same drawing as FIG. 2.
- FIG. 4 shows a different solution where the filter (1) is included inside a cigarette holder formed by a first part (7), containing the filter, and a second part (7A) where it fits and inside which the cigarette (8) is inserted.
- FIG. 5 shows a traditional cigarette (8), which embodies the filter (1).
- FIG. 6 shows the same drawing as FIG. 5, highlighting the inside of the filter (1) embodied into the cigarette (8).
- FIG. 7 shows a pipe (9) inside which the filter (1) is inserted.
- As seen in the drawings, this invention relates to a new tobacco filter material useful for the removal of noxious and irritative material from tobacco smoke. More particularly, the instant invention is concerned with an improved tobacco smoke filter material comprising stable and non toxic antioxidants and mineral compositions divided in two groups. The first group includes antioxidants such as: Ascorbic Acid, Butylparaben, Citric Acid, Glutathione, Melatonin, Resveratrol, Selenium, Ubiquinones and Green tea. The second group includes minerals such as: Activated Carbon, Clinoptilolite, Cuprous Chloride and Ferrite. All for use in such filter for the removal of noxious contaminants and free radicals from tobacco smoke.
- The embodiments of the tobacco dual smoke filter of the present invention concern of a cylindrical tobacco smoke filter (1) assembly consisting of a tube with two chamber (2, 3) separated from each other by a partition (4) of cellulose acetate made from a fibrous material selected from the group consisting of paper, cellulose acetate, viscose base and other types of plastics and/or metal, said tube may be embodied in a filter type cigarette (FIGS. 5 and 6) or in a holder for the cigarette (FIGS. 1 and 4), cigars, or pipe tobacco (FIG. 7), which such porosity to permit the passage of smoke through, said tube containing in the first chamber (3) loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion and in the second chamber (2) separated from the first one, with a cellulose acetate filtering material, consisting of non-toxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke.
- Reduced to its essential structure and with reference to the figures of the enclosed drawings, a tobacco smoke filter effective in removing harmful ingredients from cigarette smoke, comprises:
- means to remove from tobacco smoke free radicals and other harmful ingredients, and to bring the amount of such ingredients passed by the filter down well within a tolerable limit, without significantly removing moisture from the smoke and without impairing the enjoyment of smoking, by a filter composition comprising a mixture of antioxidants and minerals divided in two stages.
- means to remove free radicals, by a first chamber (3) of the filter, inside which the smoke initially pass through, which is constituted by non absorbent antioxidants;
- means to reduce the carcinogenic substances contained in the tobacco smoke, and possible residues of antioxidants, by a second chamber (2) constituted by minerals.
- FIG. 1 shows the filter at issue (1) inserted inside a cigarette holder (7) and applied to a traditional cigarette (8). FIG. 2 shows the filter in detail, with the two chambers (2, 3) separated from each other by a partition of cellulose acetate (4). The first chamber (3) contains loosely packet filter material consisting essentially of Antioxidants effective in the removal of free radical developed during the smoking combustion; the second chamber (2), separated from the first one, comprises cellulose acetate filtering material, consisting of nontoxic absorbent minerals designed to remove from tobacco smoke most of the noxious particles and gases of the tobacco smoke. The two chambers are further isolated from the external environment at their ends by two partitions of cellulose (5, 6), realized with the same material of the central one (4), which constitutes also the outside layer of the entire filter.
- FIG. 4 shows a different solution where the filter (1) is included inside a cigarette holder formed by a first part (7), containing the filter, and a second part (7A) where it fits and inside which the cigarette (8) is inserted. FIG. 5 shows a traditional cigarette (8), which embodies the filter (1). FIG. 6 shows the same drawing as FIG. 5, highlighting the inside of the filter (1) embodied into the cigarette (8). FIG. 7 shows a pipe (9) inside which the filter (1) is inserted.
- Some of the advantages and characteristics of the present invention include, but are not limited to, the following:
- 1. Tobacco smoke filter composition to insert in cigarettes, cigars and pipes, or in cigarette holders or other smoking articles, which contains several antioxidants as radicals scavenger and minerals, capable of removing a large quantity of potential harmful substances from tobacco smoke, without significantly removing moisture from the smoke and without impairing the enjoyment of smoking.
- 2. Tobacco smoke filter composition according to advantage/characteristic (“a/c”) 1, characterized by the fact that it consists of:
- antioxidants consisting of: Ascorbic Acid, Butyl-paraben, Citric Acid, L-Glutathione, Melatonin, Resveratrol, Selenium and/or its derivatives, Ubiquinones, or Green Tea;
- minerals consisting of: activated carbon, clinoptilolite (Zeolite), Cuprous Chloride and Magnetized Ferrite.
- 3. Tobacco smoke filter, constituted by the composition according to a/
c 1, characterized by the fact that it comprises: - means to remove from tobacco smoke free radicals, by a first chamber (3) of the filter, inside which the smoke initially pass through, which is constituted by non absorbent antioxidants;
- means to reduce the carcinogenic substances contained in the tobacco smoke, and possible residues of antioxidants, by a second chamber (2) constituted by minerals;
- means to separate the two chambers from each other, and possibly also from the external environment, by one (4) or more (5, 6) partitions.
- 4. Tobacco smoke filter according to a/
c - 5. Tobacco smoke filter according to a/
c - 6. Invention according to a/
c - 7. Invention according to a/
c - 8. Invention according to a/
c - 9. Invention according to a/
c - 10. Invention according to a/
c - 11. Invention according to a/
c - 12. Invention according to a/
c - 13. Invention according to a/
c - 14. Invention according to a/
c - 15. Invention according to a/
c - 16. Invention according to a/
c - 17. Invention according to a/
c - 18. Invention according to a/
c - 19. Invention according to a/
c - 20. Invention according to a/
c - 21. Invention according to a/
c - 22. Invention according to a/
c - 23. Invention according to a/
c - 24. Invention according to a/
c - 25. Invention according to a/
c - 26. Invention according to a/
c - 27. Invention according to a/
c - 28. Invention according to a/c 19, wherein it further comprises a member selected from L-Glutathione, consisting of Glutathione Peroxidase or Glutathione Reductase.
- 29. Invention according to a/c 22, wherein it further comprises a member selected from Selenium, consisting L-Selenomethionine or L-Selenocysteine.
- The instant invention has been shown and described herein in what is considered to be the most practical and preferred embodiment. It is recognized, however, that departures may be made therefrom within the scope of the invention and that obvious modifications will occur to a person skilled in the art.
Claims (25)
1. A composition for inclusion in a tobacco smoke filter for cigarettes, cigars, pipes, cigarette holders or other smoking articles, said composition comprising:
one or more antioxidants as radicals scavenger; and
one or more minerals capable of removing a large quantity of potential harmful substances from tobacco smoke and without significantly removing moisture from the smoke.
2. The tobacco smoke filter composition of claim 1 , wherein said one or more antioxidants consist essentially of Ascorbic Acid, Butyl-paraben, Citric Acid, L-Glutathione, Melatonin, Resveratrol, Selenium and/or its derivatives, Ubiquinones, or Green Tea
3. The tobacco smoke filter composition of claim 1 wherein said one or more minerals consisting essentially of: activated carbon, clinoptilolite (Zeolite), Cuprous Chloride and Magnetized Ferrite.
4. The tobacco smoke filter composition of claim 2 wherein said one or more minerals consisting essentially of: activated carbon, clinoptilolite (Zeolite), Cuprous Chloride and Magnetized Ferrite.
5. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants act as a free radical scavenger.
6. The tobacco smoke filter composition of claim 1 wherein said one or more minerals eliminate to a significant extent the carcinogenic substance contained in the tobacco smoke.
7. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants and said one or more minerals are provided in an amount between approximately 50 to approximately 100 mg.
8. The tobacco smoke filter composition of claim 7 further comprising a magnetized active carbon composition, comprising activated carbon and a magnetized ferrite powder.
9. The tobacco smoke filter composition of claim 8 wherein the magnetized active carbon and the minerals absorb a variety of gaseous components.
10. The tobacco smoke filter composition of claim 8 wherein the magnetized active carbon has a catalytic effect on sulphurous acid gas, nitrogen oxides, ozone and chlorine.
11. The tobacco smoke filter composition of claim 8 wherein the activated carbon is an activated charcoal having a specific surface area exceeding a million square centimetres per gram, a particle size between about 8 to about 50 mesh and impregnated with about 1% to about 3% by weight thereof of a magnetized micro-powdered ferrite in an amount not exceeding about 14% of the weight of the charcoal granules.
12. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Ascorbic Acid in an amount between approximately 0.1 to approximately 60 mgs.
13. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Butylparaben in an amount between approximately 0.01 mgs. to approximately 5 mgs.
14. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Citric Acid in an amount between approximately 0.1 mgs. to approximately 10 mgs.
15. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least L-Glutathione in an amount between approximately 0.01 mgs. to approximately 20 mgs.
16. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Melatonin in an amount between approximately 0.1 mgs. to approximately 2 mgs.
17. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Resveratrol in an amount between approximately 0.01 mgs to approximately 2 mgs.
18. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Selenium in an amount between approximately 0.01 mcgs. to approximately 10 mcgs.
19. The tobacco smoke filter composition of claim 1 wherein said one or more minerals comprises at least Activated Carbon in an amount between approximately 0.1 mgs. to approximately 60 mgs.
20. The tobacco smoke filter composition of claim 1 wherein said one or more minerals comprises at least Clinoptilolite (Zeolite) in an amount between approximately 0.1 mgs. to approximately 60 mgs.
21. The tobacco smoke filter composition of claim 1 wherein said one or more minerals comprises at least Cuprous Chloride in an amount between approximately 0.1 mgs. to approximately 15 mgs.
22. The tobacco smoke filter composition of claim 1 wherein said one or more minerals comprises at least Magnetized Ferrite in an amount between approximately 0.1 mgs. to approximately 30 mgs.
23. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least Green Tea in an amount between approximately 0.1 mgs. to approximately 0.15 mgs.
24. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least a member selected from L-Glutathione, consisting essentially of Glutathione Peroxidase or Glutathione Reductase.
25. The tobacco smoke filter composition of claim 1 wherein said one or more antioxidants comprises at least a member selected from Selenium, consisting essentially of L-Selenomethionine or L-Selenocysteine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/657,473 US20040045566A1 (en) | 2001-03-01 | 2003-09-08 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPEP01125053.7 | 2001-03-01 | ||
EP01125053A EP1238594B1 (en) | 2001-03-05 | 2001-10-22 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
US10/085,806 US6615843B2 (en) | 2001-03-01 | 2002-02-28 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
US10/657,473 US20040045566A1 (en) | 2001-03-01 | 2003-09-08 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/085,806 Division US6615843B2 (en) | 2001-03-01 | 2002-02-28 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040045566A1 true US20040045566A1 (en) | 2004-03-11 |
Family
ID=31995453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/657,473 Abandoned US20040045566A1 (en) | 2001-03-01 | 2003-09-08 | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
Country Status (1)
Country | Link |
---|---|
US (1) | US20040045566A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005102080A1 (en) * | 2004-04-22 | 2005-11-03 | G.D Societa' Per Azioni | Cigarette filter and relative production method |
US20050279374A1 (en) * | 2004-04-14 | 2005-12-22 | Philip Morris Usa Inc. | Reduction of phenolic compound precursors in tobacco |
WO2006051422A1 (en) * | 2004-11-10 | 2006-05-18 | Philip Morris Products S.A. | Capsuled adsorbent flavored filter |
WO2007028476A2 (en) * | 2005-09-05 | 2007-03-15 | Rhodia Acetow Gmbh | Filter or filter element for tobacco smoke. cigarette containing such a filter or filer element and method for producing such a filter or filter element |
US20070235046A1 (en) * | 2006-03-31 | 2007-10-11 | Philip Morris Usa Inc. | Smoking articles comprising magnetic filter elements |
EP2130444A1 (en) * | 2008-06-06 | 2009-12-09 | Xavier Wertz | Smokable material and smokable articles |
DE102008037337A1 (en) * | 2008-08-11 | 2010-02-25 | Hermann-Josef Wilhelm | Process for the preparation of active substances, in particular phenols from a plant |
US20110083686A1 (en) * | 2009-10-09 | 2011-04-14 | Philip Morris Usa Inc. | Method and apparatus for manufacture of smoking article filter assembly including electrostatically charged fibers |
US20110162664A1 (en) * | 2008-09-17 | 2011-07-07 | Yonglin Liang | Alexipharmic cigarette filter material and their praparation |
WO2012130609A1 (en) | 2011-04-01 | 2012-10-04 | Iasomai Ab | New combination comprising n-acetyl-l-cysteine and its use |
CN104869853A (en) * | 2012-12-21 | 2015-08-26 | 英美烟草(投资)有限公司 | Insertable filter unit |
US10473323B2 (en) * | 2016-04-12 | 2019-11-12 | Brendan J. SQUASHIC | Loading tube |
DE202022105551U1 (en) | 2021-09-30 | 2023-05-15 | Chrabkowski, Patrick "Trober Polska Patrick Chrabkowski" | Evaporator with active filter |
WO2024052553A1 (en) | 2022-09-08 | 2024-03-14 | Iasomai Ab | Combination comprising n-acetyl-l-cysteine, selenomethionine and melatonine for treatment of anxiety disorder |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4260523A (en) * | 1975-02-26 | 1981-04-07 | Siako Tsukamoto | Magnetized active carbon composition |
US5060672A (en) * | 1989-04-28 | 1991-10-29 | Pesci Dohanygyar | Highly efficient tobacco smoke filter |
US6415798B1 (en) * | 1997-09-19 | 2002-07-09 | Thione International, Inc. | Antioxidants to neutralize tobacco free radicals |
-
2003
- 2003-09-08 US US10/657,473 patent/US20040045566A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4260523A (en) * | 1975-02-26 | 1981-04-07 | Siako Tsukamoto | Magnetized active carbon composition |
US5060672A (en) * | 1989-04-28 | 1991-10-29 | Pesci Dohanygyar | Highly efficient tobacco smoke filter |
US6415798B1 (en) * | 1997-09-19 | 2002-07-09 | Thione International, Inc. | Antioxidants to neutralize tobacco free radicals |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050279374A1 (en) * | 2004-04-14 | 2005-12-22 | Philip Morris Usa Inc. | Reduction of phenolic compound precursors in tobacco |
US7581543B2 (en) | 2004-04-14 | 2009-09-01 | Philip Morris Usa Inc. | Reduction of phenolic compound precursors in tobacco |
US20080029115A1 (en) * | 2004-04-22 | 2008-02-07 | G.D Societa' Per Azioni | Method of Production of a Cigarette Filter |
US7625328B2 (en) | 2004-04-22 | 2009-12-01 | G.D. Societa' Per Azioni | Method of production of a cigarette filter |
WO2005102080A1 (en) * | 2004-04-22 | 2005-11-03 | G.D Societa' Per Azioni | Cigarette filter and relative production method |
US20060112964A1 (en) * | 2004-11-10 | 2006-06-01 | Philip Morris Usa Inc. | Capsuled adsorbent flavored filter |
EA010811B1 (en) * | 2004-11-10 | 2008-12-30 | Филип Моррис Продактс С.А. | Capsuled adsorbent flavored filter |
WO2006051422A1 (en) * | 2004-11-10 | 2006-05-18 | Philip Morris Products S.A. | Capsuled adsorbent flavored filter |
WO2007028476A3 (en) * | 2005-09-05 | 2007-07-26 | Rhodia Acetow Gmbh | Filter or filter element for tobacco smoke. cigarette containing such a filter or filer element and method for producing such a filter or filter element |
WO2007028476A2 (en) * | 2005-09-05 | 2007-03-15 | Rhodia Acetow Gmbh | Filter or filter element for tobacco smoke. cigarette containing such a filter or filer element and method for producing such a filter or filter element |
US20100037905A1 (en) * | 2005-09-05 | 2010-02-18 | Maurer Guenter | Filter or filter element for tobacco smoke cigarette containing such a filter or filter element and method for producing such a filter or filter element |
US20070235046A1 (en) * | 2006-03-31 | 2007-10-11 | Philip Morris Usa Inc. | Smoking articles comprising magnetic filter elements |
EP2130444A1 (en) * | 2008-06-06 | 2009-12-09 | Xavier Wertz | Smokable material and smokable articles |
WO2009147515A1 (en) * | 2008-06-06 | 2009-12-10 | Xavier Wertz | Smokable material and smokable articles |
DE102008037337A1 (en) * | 2008-08-11 | 2010-02-25 | Hermann-Josef Wilhelm | Process for the preparation of active substances, in particular phenols from a plant |
US9861124B2 (en) | 2008-09-17 | 2018-01-09 | Yonglin Liang | Alexipharmic cigarette filter material and their preparation |
US20110162664A1 (en) * | 2008-09-17 | 2011-07-07 | Yonglin Liang | Alexipharmic cigarette filter material and their praparation |
US8534294B2 (en) | 2009-10-09 | 2013-09-17 | Philip Morris Usa Inc. | Method for manufacture of smoking article filter assembly including electrostatically charged fiber |
US20110083686A1 (en) * | 2009-10-09 | 2011-04-14 | Philip Morris Usa Inc. | Method and apparatus for manufacture of smoking article filter assembly including electrostatically charged fibers |
US9788572B2 (en) | 2009-10-09 | 2017-10-17 | Philip Morris Usa Inc. | Method and apparatus for manufacture of smoking article filter assembly including electrostatically charged fibers |
US10226070B2 (en) | 2009-10-09 | 2019-03-12 | Philip Morris Usa Inc. | Filter rod including electrostatically charged fibers |
WO2012130609A1 (en) | 2011-04-01 | 2012-10-04 | Iasomai Ab | New combination comprising n-acetyl-l-cysteine and its use |
US10300038B2 (en) | 2011-04-01 | 2019-05-28 | Iasomai Ab | Combination comprising N-acetyl-L-cysteine and its use |
US11207287B2 (en) | 2011-04-01 | 2021-12-28 | Iasomai Ab | Combination comprising N-acetyl-L-cysteine and its use |
CN104869853A (en) * | 2012-12-21 | 2015-08-26 | 英美烟草(投资)有限公司 | Insertable filter unit |
US11076636B2 (en) | 2012-12-21 | 2021-08-03 | Nicoventures Trading Limited | Insertable filter unit |
US11419362B2 (en) | 2012-12-21 | 2022-08-23 | Nicoventures Trading Limited | Insertable filter unit |
US10473323B2 (en) * | 2016-04-12 | 2019-11-12 | Brendan J. SQUASHIC | Loading tube |
DE202022105551U1 (en) | 2021-09-30 | 2023-05-15 | Chrabkowski, Patrick "Trober Polska Patrick Chrabkowski" | Evaporator with active filter |
WO2024052553A1 (en) | 2022-09-08 | 2024-03-14 | Iasomai Ab | Combination comprising n-acetyl-l-cysteine, selenomethionine and melatonine for treatment of anxiety disorder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6615843B2 (en) | Tobacco smoke filter and relative composition made of antioxidant and mineral substances | |
RU2123271C1 (en) | Method of manufacturing filter for tobacco smoke, filter, cigarette, and method of filtering tobacco smoke | |
US20040045566A1 (en) | Tobacco smoke filter and relative composition made of antioxidant and mineral substances | |
JP3966856B2 (en) | Activated carbon filter for reducing p-benzosemiquinone from tobacco mainstream smoke | |
CN1118250C (en) | Smoking products containing antioxidants | |
US6470894B2 (en) | Glutathione, green tea, grape seed extract to neutralize tobacco free radicals | |
WO2002001974A1 (en) | Antioxidants to neutralize tobacco free radicals | |
CA2760265C (en) | Cigarette filter | |
US20090126747A1 (en) | Plant extracts and uses thereof in filter systems | |
WO2006097010A1 (en) | AN INSTANT ADDITIVE SOLUTION FOR THE FILTER OF CIGARETTl, ITS PRODUCTION METHOD AND USE | |
EP1309253B1 (en) | Methods and devices for removing nucleophilic toxins from tobacco and tobacco smoke | |
WO2008125990A2 (en) | Use of means for trapping co2 in a filter for preventing inflammation, cancer and cardiovascular diseases in a subject exposed to tobacco smoke | |
US20100108083A1 (en) | Use of means for trapping co2 in a filter for preventing inflammation, cancer and cardiovascular diseases in a subject exposed to tobacco smoke | |
KR100640190B1 (en) | Preventer of nicotine and preparation method thereof | |
EP3448181B1 (en) | New cigarette filter containing alginite | |
RU2330592C1 (en) | Filter for cigarettes | |
KR100368862B1 (en) | Cigarette Filter for Easily Removing Harzardous material like nicotine and tar | |
KR200189216Y1 (en) | Cigarette filter | |
KR20010044294A (en) | Manufacturing method of charcoal tobacco filter to remove inhalation of harmful ingredients | |
KR20130017106A (en) | Device removing the tabacco smoke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LLOYDS INTERNATIONAL CREDIT, LLC, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PERA, IVO;REEL/FRAME:018883/0393 Effective date: 20061127 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |